
Catalog Advanced Search
-
Contains 1 Component(s) Includes a Live In-Person Event on 04/12/2024 at 7:45 AM (EDT)
April 12-14, 2024
2024 ACMT Annual Scientific Meeting
April 12-14, 2024
Omni Shoreham Hotel, Washington, DCThe ACMT Annual Scientific Meeting (ASM) is an opportunity for specialists in the field to gather together to learn from the cutting-edge research of their peers. In addition to all the networking and social opportunities that make our events so rich with engagement, this year ACMT is piloting concurrent sessions offering more educational content than ever before! These concurrent sessions will be divided into the following topical tracks of broad interest to the Medical Toxicology community: 1) Environmental & Occupational Medicine, 2) Addiction Medicine, 3) Diversity, Equity & Inclusion, and 4) Research.
Continuing Education
Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person or watch them on-demand after the event.
Book Hotel
ACMT has secured a discounted rate at the Omni Shoreham Hotel in Washington, DC for attendees of our 2024 ACMT Annual Scientific Meeting. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Key Dates
Accepting Abstract Submissions: September 1 - November 15, 2023
Early Bird Registration Opens: October 2, 2023
MTF Spadafora, Shannon, J&J Travel Award Deadlines: October 2, 2023
Becker Medal Deadline: October 27, 2023
Abstract Student/Resident and International Travel Awards Deadline: November 15, 2023 (Abstract deadline)
MedTox Shark Tank Research Forum application deadline: December 4, 2023
MedTox Case Panel application deadline: December 18, 2023
Abstract Notifications: Mid December 2023
Open Mic Competition application deadline: January 15, 2024
Early Bird Registration Ends: February 20, 2024
2024 ACMT: April 12-14, 2024
Questions?
Please write to ACMT at events@acmt.net
Preliminary Agenda
This agenda is subject to change. All times listed are in local, Eastern Time Zone.
Friday, April 12, 2024
7:45 - 8:00 AM - Welcome & Introductions
8:00 - 9:00 AM - Platform Session 1
9:00 - 9:45 AM
Donovan Lectureship | Groundbreaking Research from NIDA Addressing the Challenges of the Opioid Epidemic
Nora D. Volkow, MD, Director, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Washington, DC
This lectureship is supported by the Medical Toxicology Foundation through the Ward and Ryan Donovan Memorial Fund. For more info, please visit: www.acmt.net/donovan-lectureship
9:45 - 10:45 AM
Chemical Defense: Assessing and Optimizing Local Responses
Mark Kirk, MD, Senior Advisor, Chemical Defense, DHS Countering Weapons of Mass Destruction, Department of Homeland Security, Washington, DC
The Past, Present, and Future of Contributions of the United States Army Medical Research Institute of Chemical Defense to Chemical Casualty Care
Daniel Nogee, MD, MHS, Medical Toxicologist, Chemical Casualty Care Division, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD
10:45 - 11:45 AM - Poster Session 1
10:55 - 11:35 AM - Moderated Poster Forum 1
11:45 - 1:00 PM - Break / Committee Meetings
Tracks 1:00-1:30 PM ET - Concurrent Sessions
Pick one to attend live, watch the others on-demand after (if available)Availability Environmental & Occupational
MedicineHarmful Algal Blooms (HABs): What Poison Centers and Medical Toxicologists Should Know
Brett E. Johnson, MD, Emergency Medicine Physician, UMass Memorial Medical Center, Worcester, MA
Mindy Richlen, PhD, Research Specialist, Biology, Woods Hole Oceanographic Institution, Woods Hole, MA
Michael J. Twiner, MD, PhD, Department of Emergency Medicine, Wayne State University, Detroit, MI
Moderator: Jeffrey Lai, MD, Assistant Professor of Emergency Medicine, UMass Memorial, Worcester, MALive
+
On-DemandAddiction
MedicineMedication for Opioid Use Disorder Trajectory Phenotypes: Development of a Risk Stratification and Prediction Framework Using Urine Toxicology and EHR Data
Albert Burgess-Hull, PhD, Head Data Scientist, MATClinics, University of Maryland, Baltimore, MD
Live
+
On-DemandDiversity, Equity
& InclusionThe Toxic Past and Present of Redlining and Racial Segregation
Sean D. McCann, MD, Assistant Professor of Clinical Emergency Medicine and Medical Toxicology, University of Illinois Chicago, Chicago, IL
Moderator: Noah Berland, MD, MS, Assistant Division Director Medical Toxicology, Kings County Hospital, Newark, NJLive
+
On-DemandResearch Researchers, Do You Even R? Getting Started with Managing and Visualizing Toxicology Data in R
Hannah Spungen, MD, MPH, Toxicology Fellow, Banner University Medical Center-Phoenix, Phoenix, AZ
Live
+
On-Demand1:30 - 1:40 PM ET - Break / Transition Time
Tracks 1:40-2:10 PM ET - Concurrent Sessions
Pick one to attend live, watch the others on-demand after (if available)Availability Environmental & Occupational
MedicineMad About Manganese: Medical Toxicologists and Water Quality Standards
Richard Hamilton, MD, MBA, FACMT, FACEP, FAAEM, Professor and Chair of Emergency Medicine, Drexel University College of Medicine Philadelphia, PA
Live
+
On-DemandAddiction
MedicineThe Public Health Impact of Over-The-Counter Naloxone & Nalfamene
Michael Toce, MD, MS, FACMT, Assistant Professor of Pediatric and Emergency Medicine, Harvard Medical School, Boston, MA
Live
+
On-DemandDiversity, Equity
& InclusionThe Good, Bad and Ugly: Drug Testing in Liver Transplant Evaluations
JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN
Soumya L. Pandalai, MD, FACP, FASAM, Internist, Banner-University Medical Center Phoenix, Phoenix, AZ
Robert C. Pueringer, MD, Medical Toxicologist and Addiction Medicine Specialist, Essentia Health, Duluth, MN
Stephanie T. Weiss, MD, PhD, Staff Research Physician, Translational Addiction Medicine Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MDLive
ONLYResearch Translational Approach to Biomarker and Therapeutic Development in Environmental Toxicology
David Jang, MD, MSc, FACMT, Assistant Professor, University of Pennsylvania School of Medicine, Philadelphia, PA
Live
ONLY2:10 - 2:20 PM ET - Break / Transition Time
Tracks 2:20-2:50 PM ET - Concurrent Sessions
Pick one to attend live, watch the others on-demand after (if available)Availability Environmental & Occupational
MedicineDo You Really Know IARC? Why IARC Determinations Aren’t Clear Cut, and When They Result in Controversy
John Downs, MD, MPH, Associate Professor and Associate Program Director, Occupational & Environmental Medicine Residency, Uniformed Services University, Bethesda, MD
Kevin F. Maskell, Jr., MD, Assistant Professor of Military and Emergency Medicine, Brooke Army Medical Center, Jbsa Ft Sam Houston, TXLive
+
On-DemandAddiction
MedicinePsilocybin and the Treatment of Substance Use Disorder
Albert Garcia-Romeu, PhD, Assistant Professor, Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
Live
ONLYDiversity, Equity
& InclusionToxicology Practice and Gender and Sexual Minorities
Sarah Weiss, MD, MBS, Director of Medical Toxicology, Reading Hospital, Tower Health, Sinking Spring, PA
Live
+
On-DemandResearch Translational Research from Laboratory Bench to Clinical Practice: Digoxin Poisoning
Betty Shuk Han Chan, MBBS, PhD A/Prof, Prince of Wales Hospital, Sydney, Australia
Live
+
On-Demand2:50 - 3:00 PM ET - Break / Transition Time
Tracks 3:00-3:30/45 PM ET - Concurrent Sessions
Pick one to attend live, watch the others on-demand after (if available)Availability
Environmental & Occupational
MedicineTesting and Counseling on Polyfluoroalkyl Substances (PFAS) exposure in the Medical Toxicology Clinic
Nicholas Erick Nacca, MD, Assistant Professor of Emergency Medicine, University of Rochester Medical Center, Rochester, NY
John Downs, MD, MPH, Associate Professor and Associate Program Director, Occupational & Environmental Medicine Residency, Uniformed Services University, Bethesda, MD
Elizabeth Boyle, MPH, CIH, Senior Program Officer, Board on Population Health and Public Health Practice, National Academies of Sciences, Engineering, and Medicine, Washington, DCModerator: Michael Holland, MD, FACMT, FAACT, FEACCT, FACOEM, FACEP, SUNY Upstate Medical University, Syracuse, NY
Note: to accommodate additional speakers this session has been extended and will now be 45 min (3:00-3:45 PM ET)
Live
+
On-DemandAddiction
MedicineAnnual Review of Medical Toxicology Publications - Articles You May Have Missed from 2023-2024
Dan McCabe, MD, Director of the Division of Medical Toxicology & Associate Medical Director, University of Iowa & Iowa Poison Control Center, Iowa City, IAM/p>
Live
+
On-Demand
Diversity, Equity
& InclusionTrauma-Informed Care for the Medical Toxicologist
Vinodinee L. Dissanayake, MD, MPH, Assistant Professor, Department of Emergency Medicine, Rush University Medical Center, Chicago, IL
Antonia Nemanich, MD, Assistant Professor, Rush University Medical Center, Chicago, IL
Jenna Nikolaides, MD, MA, FACEP, Assistant Professor, Department of Emergency Medicine, Rush University Medical Center, Chicago, IL
Trevonne Thompson, MD, FACEP, FACMT, Associate Dean of Admissions, University of Illinois College of Medicine at University of Illinois at Chicago, Chicago, ILLive
ONLY
ResearchAnatomy of Authorship
Mark Mycyk, MD, Editor in Chief; Research Chair, Journal of Med Tox; Cook County Health, Chicago, IL
Live
+
On-Demand
3:30/45 - 5:00 PM - Break / Committee Meetings
5:00 - 6:00 PM - ACMT Annual Members Meeting and Awards Ceremony
6:00 - 8:00 PM - President's Reception
Saturday, April 13, 2024
7:45 - 8:00 AM - Morning Announcements
8:00 - 9:00 AM - Platform Session 2
9:00 - 9:45 AM
Panel | The East Palestine Disaster: Toxicological Considerations
Joseph Cocciardi, PhD, MS, FAIHA, CIH, CSP, REHS/RS, Founding Principal, Cocciardi and Associates, Inc.; Senior Health & Safety Professional, Pennoni, Mechanicsburg, PA
Michael Kosnett, MD, MPH, FACMT, Associate Clinical Professor, Department of Environmental & Occupational Health, University of Colorado School of Medicine and School of Public Health, Denver, CO
Charles McKay, MD, FACMT, Associate Medical Director, Connecticut Poison Control Center, University of Connecticut School of Medicine, Marlborough, CT
Anthony Pizon, MD, FACMT, Chief of Medical Toxicology Division, Professor of Emergency Medicine, University of Pittsburgh, Pittsburgh, PAModerator: Emily Kiernan, DO, FACEP, Assistant Professor, Emory University, Atlanta, GA
9:45 - 10:30 AM
ACMT Career Achievement Award
10:30- 11:30 AM - Poster Session 2
10:40 - 11:20 AM - Moderated Poster Forum 2
11:30 - 1:00 PM - Break / Committee Meetings
1:00 - 2:00 PM
AACT Panel | TBA
Developed in Collaboration with the American Academy of Clinical Toxicology (AACT).
2:00 - 3:30 PM - MedTox Case Panel: Case-Based Conundrums
3:30 - 5:00 PM - MTF Shark Tank Research Forum
5:00 - 7:00 PM - Open Mic Competition
Sunday, April 2, 2023
7:50 - 8:00 AM - Morning Announcements
8:00 - 9:00 AM - Lightning Oral Session
9:00 - 10:45 AM
International Panel
Developed in Collaboration with the Middle East & North Africa Clinical Toxicology Association (MENATOX), Asia Pacific Association of Medical Toxicology (APAMT), and the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT).
10:45 - 11:00 AM - Break (15 min)
11:00 - 12:00 PM
ASAM Panel | NIDA Research & ED Experience with XR Injectable Buprenorphine
Kristen Huntley, PhD, Associate Director, Addiction Medicine Team Leader, Center for the Clinical Trials Network, National Institute on Drug Abuse, NIH, DHHS, Washington, DC
Gail D'Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine, Professor of Epidemiology (Chronic Diseases) and Professor of Medicine Core Addiction, Yale School of Medicine, New Haven, CT
Joseph Carpenter, MD, Assistant Professor, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA
Jon Cole, MD, FACMT, Emergency Physician and Medical Toxicologist, Hennepin County Medical Center; Medical Director, Minnesota Poison Control System, Minneapolis, MNModerator
Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NYDeveloped in Collaboration with the National Institute on Drug Abuse (NIDA) and the American Society of Addiction Medicine (ASAM).
12:00 - 12:45 PM
Achieving Health Equity in the Field of Substance Use: A Public Health Approach
Carla Foster, MPH, Epidemiologist and Principal Investigator, New York City Department of Health and Mental Hygiene, New York, NY
12:45 - 1:45 PM - Poster Session 3
12:55 - 1:35 PM - Moderated Poster Forum 3Hassan Al Balushi, MD, OMSB-EM
Emergency Medicine Consultant and Medical Toxicologist
Suhar Hospital, Minitry of Health
Dr. Hassan is an Emergency Medicne Consultant and Medical Toxicologist From Oman, Completed his Medical Degree at Sultan Qaboos University Medical School in Oman in 2013. Completed his Emergency Residency Program and Board at Oman Medical Specialty Board (OMSB), Oman. Completed a 2 year fellowship program in Medical Toxicology at Emory University, Georgea, USA. Dr. Al Balushi is an active member of Middle East and North Africa Medical Toxicology Association (MENATOX), as well as a board member and the secretary of Oman Society of Emergency Medicine (OSEM).
Noah Berland, MD, MS
Assistant Division Director Medical Toxicology
Kings County Hospital
Dr. Noah Berland is an emergency physician and assistant division director of medical toxicology at NYC H+H Kings County Hospital Center. Prior to studying Medicine Dr. Berland obtained a Bachelors and Masters in Electrical Engineering. Dr. Berland obtained his MD from NYU School of Medicine and completed his Emergency Medicine Residency at SUNY Downstate - Kings County Hospital. Dr. Berland went on to complete his Medical Toxicology Fellowship and Rutgers NJMS in Newark NJ.
Albert Burgess-Hull, PhD
Head Data Scientist, SUDx/MATClinics
University of Maryland
Albert Burgess-Hull is a Data Scientist and Machine Learning Researcher at MATClinics, an outpatient addiction treatment center in Maryland that specializes in Opioid Addiction Treatment. He received his PhD from the University of Wisconsin - Madison and completed postdoctoral fellowship training at the National Institute on Drug Abuse’s Intramural Research Program. Albert’s research focuses on the development and validation of digital diagnostic and prognostic frameworks for the classification and prediction of treatment related outcomes in addiction medicine. He is also interested in how the use of advanced clustering/segmentation methodologies can be used for the development of precision medicine frameworks to deliver the optimal treatment to the right patient at the right time.
Betty Shuk Han Chan, MBBS, PhD
Associate Professor
Prince of Wales Hospital
A/Prof Betty Chan is a clinical toxicologist and emergency physician with major interests in cardiovascular drug poisonings, antidotes and cognitive function following poisoning. She is an Associate Professor with the University of New South Wales – Head of the Discipline of Critical Care, a consultant with the NSW Poisons Information Centre and an associate Editor of the journal Clinical Toxicology. She is an emergency physician, head of the Clinical Toxicology unit at Prince of Wales Hospital, South Eastern Area Toxicology Service (SEATS). Her research findings have led to a change of clinical guidelines in the use of digoxin-Fab in acute and chronic digoxin poisonings, folinic acid in acute and chronic methotrexate poisoning. She has initiated a number of projects which have provided clinical data for further studies in tapentadol poisoning, the use of haemodialysis for acute and chronic lithium poisoning, digoxin-Fab supply and demand, optimal methods to manage severe tricyclic antidepressant and dihydropyridine poisonings.
John Downs, MD, MPH
Associate Professor and Associate Program Director
Occupational & Environmental Medicine Residency, Uniformed Services University
John W. Downs, MD, MPH is a graduate of the Virginia Military Institute and served two years as a US Army infantry officer, prior to attending medical school at the Uniformed Services University of the Health Sciences (USU). Dr. Downs completed residency training in internal medicine at Tripler Army Medical Center, Honolulu, Hawaii, and in occupational & environmental medicine at USU, where he also completed a Master of Public Health (MPH) degree. Dr. Downs later completed fellowship in medical toxicology at the Virginia Commonwealth University Health System-Medical College of Virginia. Dr. Downs is currently stationed at the Uniformed Services University where he is an Associate Professor and the Associate Program Director for the occupational and environmental medicine residency, and an attending physician at Walter Reed National Military Medical Center. Dr. Downs is board certified in internal medicine, occupational medicine, and medical toxicology, and is a certified public health professional (CPH). He is a Fellow of the American College of Physicians, and the American College of Occupational and Environmental Medicine.
Albert Garcia-Romeu, PhD
Associate Professor, Behavioral Pharmacology Research Unit
Johns Hopkins University
Albert Garcia-Romeu, Ph.D. is an Associate Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. His current research interests include clinical applications of psychedelics, real-world drug use patterns, diversity in science, and the role of spirituality in mental health. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research and the International Society for Research on Psychedelics. He serves on the Board of Directors for the College on Problems of Drug Dependence (CPDD) and is an Associate Editor for the journal Psychedelic Medicine.
Richard Hamilton, MD, MBA, FACMT, FACEP, FAAEM
Professor and Chair of Emergency Medicine
Drexel University College of Medicine
Dr. Hamilton is Professor and Chair, Emergency Medicine, Drexel University College of Medicine. He is the Chief Academic Officer, DIO, and Regional Associate Dean for the Crozer Keystone Campus and EM System Chair of the Crozer Keystone Health System. Dr. Hamilton's research interests include PFAS and Manganese drinking water standards. He has received awards for his teaching and research and is a widely published author of manuscripts, textbooks, and book chapters, and patents.
Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP
Director of Occupational Medicine
Saratoga Hospital
Dr. Holland is the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees.
Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and at the Onondaga County Medical Examiner’s Office-both in Syracuse, NY.
He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.
Geoff Isbister, MD
Professor, School of Medicine and Public Health
University of Newcastle
I am a Professor and NHMRC Senior Research Fellow at the University of Newcastle. I am a consultant clinical toxicologist and emergency physician, Director of the Department of Clinical Toxicology, Calvary Mater Hospital and consultant toxicologist to the NSW Poisons Information Centre. I was made a Member of the Order of Australia in 2019 for my contribution to toxicology. I am President Elect of the Asia Pacific Assocation of Medical Toxicologists. My major area of research is snake bite. I have published over 375 papers and received $20 million in research funds.
Emily Kiernan, DO
Assistant Professor of Emergency Medicine and Medical Toxicology
Emory University School of Medicine
Dr. Kiernan is an Assistant Professor at Emory University School of Medicine. She is a board-certified Emergency Medicine physician who recently completed a medical toxicology fellowship at Emory University/CDC. She has served as the fellow co-chair for the AACT Radiation Special Interest Section group as well as a chair in the ACMT Fellow-in-training association.
Kathryn Kopec, DO, FACMT
Associate Professor, Division Director of Medical Toxicology
Carolinas Medical Center
Dr. Kathryn Kopec is currently an Associate Professor of Emergency Medicine and the Director of the Medical Toxicology Division at Carolinas Medical Center in Charlotte, NC. Dr. Kopec obtained her bachelor's degree in biology from the University of Dayton and her medical degree from Michigan State College of Osteopathic Medicine. She completed her Emergency Medicine residency and Medical Toxicology fellowship at Einstein Medical Center in Philadelphia, PA. She is currently on the ACMT Board of Directors. Academically her interests involved global toxicology, drugs of abuse, agitated delirium and toxicology education.
JoAn Laes, MD, DFASAM, FACMT
Addiction Staff Physician
Abbott Northwestern Hospital, Allina Health
JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.
Jeffrey Lai, MD
Assistant Professor of Emergency Medicine
UMass Memorial
Jeffrey Lai, MD, is an emergency physician and medical toxicologist at UMass Chan Medical School and UMass Memorial Health. He is the medical toxicology fellowship director and the clerkship director for the Introduction to Medical Toxicology elective at UMass Chan Medical School. His academic interests include medical education, the application of novel technologies to the treatment of substance use disorder, and the surveillance of impairing substances in patients with severe traumatic injuries.
Dan McCabe, MD
Clinical Associate Professor & Director, Division of Medical Toxicology
University of Iowa Hospitals & Clinics, Iowa Poison Control Center
Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Associate Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Medical Director of the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.
Sean D. McCann, MD
Assistant Professor of Clinical Emergency Medicine and Medical Toxicology
University of Illinois Chicago
Charles McKay, MD, FACMT
Associate Medical Director
CT Poison Control Center, University of Connecticut School of Medicine
Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.
Elisabeth Moore, DO
Assistant Professor of Clinical Emergency Medicine
Weill Cornell Medicine
Dr. Moore is currently an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at Weill Cornell Medicine in New York City. She completed her Emergency Medicine Residency training at Lehigh Valley Health Network in and her Fellowship in Medical Toxicology at Banner-University Medical Center in Phoenix. She is actively involved in Women in Toxicology (WiT), and helps to produce the “Tox in Ten” and “ ACMT Highlights” Podcast.
Mark Mycyk, MD, FACMT
Chair of Research
Cook County Health
Dr. Mycyk currently serves as the Chair of Research for the Department of Emergency Medicine at Cook County Health. He is a board member of several biomedical journals, including service as Editor-in-Chief of Journal of Medical Toxicology and Associate Editor of Academic Emergency Medicine. Dr. Mycyk received an AB in English and American Literature and Language from Harvard College and an MD from University of Illinois. He completed his Residency in Emergency Medicine at Boston City Hospital/Boston Medical Center and his fellowship at Toxikon Consortium.
Nicholas Nacca, MD
Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Associate Fellowship Director of Medical Toxicology Fellowship Program
University of Rochester Medical Center
Dr. Nacca was born Rochester NY. He completed his undergraduate work at University of Rochester with a Bachelor of Science in Neuroscience. He completed medical school, Emergency Medicine residency training, and Medical Toxicology fellowship at SUNY Upstate Medical University and the Upstate Poison Control Center. He currently works as an Emergency Physician and Medical Toxicologist at University of Rochester Medical Center where he serves as the Director of Medical Toxicology. The Medical Toxicology consult service at URMC provides 24/7 call coverage for Strong Memorial Hospital and affiliates, fielding both inpatient and outpatient consultations for management of both intentional and unintentional ingestions, overdoses, and environmental exposures. Dr. Nacca’s focus is on Medical Toxicology and Emergency Medicine education, with interest in novel psychoactive substances and adulterated drugs of abuse.
Daniel Nogee, MD, MHS
Chief of Consultation, Chemical Casualty Care Division
U.S. Army Medical Research Institute of Chemical Defense
Dr. Daniel Nogee is a board-certified medical toxicologist and emergency medicine physician currently serving as the Chief of Consultation within the Chemical Casualty Care Division (CCCD) of the United States Army Medical Research Institute of Chemical Defense (USAMRICD). Dr. Nogee earned his medical degree from the Johns Hopkins University School of Medicine. While in medical school, he completed a research year at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health campus in Bethesda, MD through the Medical Research Scholars Program. Dr. Nogee completed internship and residency in emergency medicine at Yale-New Haven Hospital, and completed a Masters in Health Sciences through the Yale University School of Medicine as well as a research fellowship in emergency medicine as part of the Yale Emergency Scholars program. Dr. Nogee completed fellowship training in Medical Toxicology through the Emory University School of Medicine-Centers for Disease Control and Prevention (CDC) Medical Toxicology Fellowship in Atlanta, GA. While serving as a medical officer for the CDC’s National Center for Environmental Health he was deployed as a field investigator for an outbreak of non-viral hepatitis in the Las Vegas area.
During medical school, Dr. Nogee commissioned as an officer in the United States Army/Maryland Army National Guard. He is currently assigned as a Field Surgeon with the 224th Medical Company (Area Support) in Olney, MD. During 2020 he deployed in support of COVID-19 response efforts in Maryland. In 2021, he deployed to the Middle East as a Battalion Surgeon with the 29th Infantry Division Headquarters and Headquarters Battalion.
Anthony Pizon, MD, FACMT
Chief of Medical Toxicology Division, Professor of Emergency Medicine
University of Pittsburgh
Dr. Anthony (Tony) Pizon received his medical degree from the University of Toledo School of Medicine in 2001. He then completed his Emergency Medicine Residency at the University of Pittsburgh Medical Center in 2004 and his Medical Toxicology Fellowship at Banner Good Samaritan Medical Center in Phoenix, Arizona in 2006. Dr. Pizon is currently a Professor in the Department of Emergency Medicine, Division of Medical Toxicology at the University of Pittsburgh, School of Medicine. He serves as Chief of the Division of Medical Toxicology and Director of the Medical Toxicology Fellowship at UPMC. He is also Assistant Medical Director of both the Pittsburgh and West Virginia Poison Centers. Yet, most importantly, he is blessed with amazing wife, Caryn, and four wonderful children (Benjamin, Elizabeth, Gabriela, and Seraphina).
Robert C. Pueringer, MD
Medical Toxicologist and Addiction Medicine Specialist
Essentia Health
Dr. Robert “Cole” Pueringer is a Medical Toxicologist, Addiction Medicine Specialist, and Hospitalist. He joined Essentia Health in September of 2022. He completed his medical training in the Twin Cities, including Medical School at the University of Minnesota, Internal Medicine Residency and Chief Resident year at Hennepin County Medical Center (HCMC). He received his CTropMed certification for Tropical Medicine & Travelers’ Health at the University of Minnesota. He then completed a Medical Toxicology fellowship at the Health Partners Institute/HCMC in 2021 and an Addiction Medicine fellowship at the University of Minnesota in 2022. His academic interests include medical education, Global Health, and the overlap of Medical Toxicology and Addiction Medicine. He is particularly passionate about substance use disorder - a disease that has affected many aspects of his own life – and hopes to contribute significantly to substance use treatment, education, de-stigmatization, and harm reduction in northern Minnesota.
Hannah Spungen, MD, MPH
Toxicology Fellow
Banner University Medical Center-Phoenix
Dr. Spungen is a second year Medical Toxicology fellow at Banner—University Medical Center Phoenix. She completed her Emergency Medicine residency at UCLA Ronald Reagan/Olive View. Her research interests include bias and spin in scientific communication, vasopressor dosing in cardiodepressant drug toxicity, and using R to explore large toxicologic data sets.
Trevonne Thompson, MD
Professor of Emergency Medicine & Medical Toxicology
University of Illinois College of Medicine/Toxikon Consortium
Dr. Trevonne M. Thompson is an attending emergency physician and medical toxicologist at UI Health and a tenured professor of Emergency Medicine and Medical Toxicology at the University of Illinois College of Medicine (UICOM). He obtained his undergraduate degree from Xavier University of Louisiana in New Orleans. After graduating with a degree in Biology and minors in Chemistry and Spanish, he attended medical school at the Feinberg School of Medicine at Northwestern University in Chicago. He served his emergency medicine residency at Cook County Hospital (now Stroger Hospital of Cook County). After serving as Chief Resident in Emergency Medicine, he completed a Medical Toxicology fellowship at the Toxikon Consortium in Chicago. Dr. Thompson is the head of the Division of Medical Toxicology within the Department of Emergency Medicine at UICOM. He leads the medical toxicology consultation service and clinic at UI Health. He is a consultant to the Illinois Poison Center and is an associate program director for the Toxikon Consortium Medical Toxicology Fellowship.
Dr. Thompson is the Associate Dean for Admissions for the University of Illinois College of Medicine. He is a past chair of the Emergency Medicine Section of the National Medical Association.
Michael Toce, MD, MS
Assistant Professor of Pediatric and Emergency Medicine
Harvard Medical School
Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center. Dr. Michael Toce conducts research that focuses on pediatric toxicology and emergency medicine. He has published on the association of state opioid reduction policies with pediatric opioid poisonings and is currently focused on assessing the association of naloxone access laws and adolescent and young adult opioid overdose.
Michael J. Twiner, MD, PhD
Assistant Professor, Department of Emergency Medicine
Wayne State University
Dr. Twiner has studied environmental toxicology for over 20 years earning his PhD from Western University (Ontario, Canada). The main focus of his early research career involved identifying and characterizing the toxicological mechanisms of marine and freshwater algal toxins with applications towards the development of molecular and biochemical detection methods as well as assessing the health effects of these toxins on marine mammals and humans. He spent several years working at the National Oceanic and Atmospheric Administration’s Center for Coastal Environmental Health and Biomolecular Research in Charleston, SC before developing his own research laboratory at the University of Michigan. He continued to carry on his research program while completing his medical degree and then residency in Emergency Medicine at Detroit Receiving Hospital, Detroit, MI USA. He is now an attending physician at Detroit Medical Center, Detroit, Michigan. He holds an academic position with Wayne State University where he continues his algal toxin research but has also branched out to work on research projects involving hypertension and heart failure in the underserved communities within and around Detroit. To date, he has published over 40 research papers.
Stephanie Weiss, MD, PhD
Staff Clinician, Translational Addiction Medicine Branch
National Institute on Drug Abuse
Dr. Stephanie Weiss is the Staff Research Physician serving the Translational Addiction Medicine Branch of the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011. She is board certified in emergency medicine, addiction medicine, and medical toxicology and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.
David Jang, MD, MSc, FACMT
Assistant Professor
University of Pennsylvania School of Medicine
We are interested in studying the interaction of mitochondrial function in the area of acute care that includes sepsis and acute poisoning. We are currently taking a translational approach studying the mitochondria at a cell-based level, to various animal models, all the way to the clinical setting actively enrolling patients with these acute medical conditions with the goal to develop better prognostic measures with the potential for mitochondrial-directed therapy.
Our lab has the latest models of the O2k-FluoRespirometer (O2k-Series H), Western blotting, confocal microscopy to study mitochondrial function in both in vitro and in vivo models with a focus on mitochondrial-directed therapies using substrate prodrugs. Relevant in vivo platforms include zebrafish, murine and porcine models of acute critical care illnesses that also combine state of the art physiological monitoring such as PV loop catheters providing realtime physiological data to be linked with cellular function. Our other interests also utilize the use of blood cells as proxy of organ cellular function as a type of biomarker which may provide prognostic function and allow clinicians to better gauge response to therapy.
Combining these elements we aim to better understand the complex interactions of both bioenergetics in issues of acute care to better improve patient care and outcomes.
Registration Rates
Registration includes:
- Access to the in-person event on April 12-14, 2024
- Access to the on-demand recordings (if provided by speaker) for 90 days after the event.
- Access to the Speaker slides
- Downloadable Certificate of Attendance
ACMT Member Rates Early-Bird Expires: Feb 20, 2024
Regular Rate Begins: Feb 21, 2024
Member Tier I: Full, Affiliate, International, Emeritus$650 $750
Member Tier II: Fellows$450 $550
Member Tier III: Residents, International - Developing Country
$350$450
Member IV: Medical Students
$250$350 Non-Member Rates Early-Bird Expires: Feb 20, 2024
Regular Rate Begins: Feb 21, 2024
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"
$950$1,050
Non-member Tier II: Fellows, SPIs, Nurses, etc.
$650$750
Non-member Tier III: Educators & Emergency Responders
$550$650
Non-member IV: Residents & Students
$450$550 Early-Bird Rate
Early-bird rates expire at midnight on FEBRUARY 20, 2024. Fees increase to the Regular Rate after this date, no exceptions.
ACMT Membership
ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership
Continuing Education
Continuing Education credit for this activity is available for an additional fee and is provided by AKH Inc., Advancing Knowledge in Healthcare. The activity is accredited for both live and enduring participation for the following:
- Physicians (Continuing Medical Education)
- Pharmacists (Continuing Pharmacy Education)
- Nurses (Continuing Nursing Education)
Cancellation Policy
Event registration cancellations received on or before February 25, 2024 (2/25/24) will receive a full refund less a 8% processing fee. Cancellations received between February 26, 2024 and March 26, 2024 (2/26/24-3/26/24) will receive a 50% refund. Cancellations made on or after March 27, 2024 (3/27/24) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.
All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Questions?
Write to: events@acmt.net
Continuing Education
Continuing Education credit for this activity will be provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
CME, CPE, and CNE Continuing Education credits are pending for this activity. It is expected that learners will receive up to 21.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
Venue Info
The 2024 ACMT Annual Scientific Meeting will take place at the Omni Shoreham Hotel in Washington, DC.
Omni Shoreham Hotel
2500 Calvert St NW
Washington, DC 20008
Booking Link
ACMT has secured a discounted rate for attendees of our 2024 ACMT Annual Scientific Meeting. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Exclusive hotel rate expires: March 18, 2024
Explore DC
The landmark Omni Shoreham Hotel is located in Washington D.C.’s premier "Woodley" residential neighborhood. An icon among hotels in Washington, D.C., the Omni Shoreham Hotel has hosted presidents, world leaders and inaugural balls since its inception in the 1930s. Hotel amenities include a heated resort pool, relaxation gardens, a state-of-the art fitness center, and a massage therapy spa. The city’s most popular attractions are also nearby - including the National Zoo, the White House, the United States Capitol and the National Mall.
-
Register
- Early bird pricing available!
- Non-member - Tier I - $950
- Non-member - Tier II - $650
- Non-member - Tier III - $550
- Non-member - Tier IV - $450
- Member - Tier I - $650
- Member - Tier II - $450
- Member - Tier III - $350
- Member - Tier IV - $250
- Regular Price after 02/20/2024 11:59 PM
- Non-member - Tier I - $1,050
- Non-member - Tier II - $750
- Non-member - Tier III - $650
- Non-member - Tier IV - $550
- Member - Tier I - $750
- Member - Tier II - $550
- Member - Tier III - $450
- Member - Tier IV - $350
- More Information
-
Contains 1 Component(s) Includes a Live In-Person Event on 04/11/2024 at 9:45 AM (EDT)
April 11, 2024
2024 ACMT Symposium | Substance Use Disorder in Adolescents and Young Adults: Unique Challenges
April 11, 2024
Omni Shoreham Hotel, Washington, DCJoin the American College of Medical Toxicology (ACMT) and the Maryland-DC Society of Addiction Medicine (MDDCSAM) on Thursday, April 11, 2024 for a Symposium on "Substance Use Disorder in Adolescents and Young Adults: Unique Challenges."
Adolescents comprise approximately 15% of the population, and the number of adolescents who use non-prescribed substances is staggering, with about 2.08 million (8.33%) of 12- to 17-year-olds nationwide reporting use within the past month. Non-prescribed substance use increased 61% among 8th graders between 2016 and 2020. Unfortunately, treatment resources are limited and there is a lack of exposure to training physicians in the treatment of these patients. Additionally, there are unique challenges within this patient population, including the on-going brain development throughout puberty and adolescence that can impact decision making and substance use. Many who are exposed to illicit substances in youth progress to develop substance use disorders as adults.The increasing novelty of substances of abuse, the rise of fentanyl and marijuana use in the adolescent population, and the overall lack of adequate treatment for this group (including medication-assisted therapy) will increase the need to have informed providers to care for this population.
This symposium gathers experts, researchers, and healthcare professionals to explore the unique challenges surrounding adolescent substance use, including biologic differences in adolescents, psycho-social motivational differences, and medication recommendations and therapeutic interventions for this patient population. This educational event is tailored for medical toxicologists, addiction medicine specialists, pediatricians, psychiatrists, psychologists, nurses, and all healthcare providers dedicated to improving the lives of young individuals battling substance use disorders.
Learning Objective 1
Understand the epidemiology and trends of adolescent SUD in the United States.Learning Objective 2
Identify the biological and psycho-social factors that differentiate adolescents from adults in the context of substance use.Learning Objective 3
Explore multifaceted SUD treatment approaches and gain greater insight into how to tailor treatment plans to meet the unique needs of adolescent patients struggling with substance use.
Continuing Education
Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person or watch them on-demand after the event.
Book Hotel
ACMT has secured a discounted rate at the Omni Shoreham Hotel in Washington, DC for attendees of our 2024 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Questions?
Please write to ACMT at events@acmt.net
Agenda
This agenda is subject to change. All times listed are in local, Eastern Time Zone.
Thursday, April 11, 2024
9:45 - 10:00 AM - Welcome & Introductions
10:00 - 10:30 AM
Developmental Vulnerabilities in Substance Use Disorders: Why Are Youth Different?
Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD
10:30 - 11:00 AM
Assessment and Treatment of SUD in Youth: Beyond SBIRT
Camille Broussard Robinson, MD, MPH, Assistant Professor of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD
11:00 - 11:30 AM
Opioid Use Disorder in Youth -- When To Consider MAT
Ann B. Bruner, MD, Pediatrician, Mountain Manor Treatment Center, Baltimore, MD
11:30 - 12:15 PM
Family Involvement in Youth SUD Treatment
Kevin Wenzel, PhD, Psychologist and Director of Research, Maryland Treatment Centers, Mountain Manor Treatment Center, Baltimore, MD
12:15 - 1:45 PM - Lunch Break
1:45 - 2:45 PM
Panel | Youth SUD Updates on Patterns & Trends, Vaping & Emerging Substances, and Cannabis
Patterns & Trends
Leslie R. Dye, MD, FACMT, FASAM, FACCT, Clinical Professor, Emergency Medicine, Assistant Medical Director, Wright State University/Boonshoft School of Medicine, OneFifteen, Dayton, OHVaping & Emerging Substances
Camille Broussard Robinson, MD, MPH, Division of Adolescent & Young Adult Medicine, Director of Research, Children’s Center Chronic Fatigue Clinic, Johns Hopkins University School of Medicine, Baltimore, MDCannabis
Jordan Davidson, Communications and Legislative Affairs Officer, Smart Approaches to Marijuana (SAM), Alexandria, VA
Moderator: Ashley Haynes, MD, FACEP, Medical Toxicologist, Addiction Medicine Specialist, Ascension Via Christi Hospitals, Andover, KS
2:45 - 3:15 PM
Developmental Effects of Cannabis and Psychiatric Consequences
Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD
3:15 - 3:30 PM - Break
3:30 - 4:15 PM
The Evidence for Replacing the Current Normalization of Youth Drug Use with a New Health Standard
Robert L. DuPont, MD, President, Institute for Behavior and Health; Clinical Professor of Psychiatry, Georgetown University School of Medicine, Rockville, MD
4:15 - 5:15 PM
Youth SUD Case-Based Panel
Ann B. Bruner, MD, Pediatrician, Mountain Manor Treatment Center, Baltimore, MD
Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD
Robert L. DuPont, MD, President, Institute for Behavior and Health; Clinical Professor of Psychiatry, Georgetown University School of Medicine, Rockville, MD
Moderator: Leslie R. Dye, MD, FACMT, FASAM, FACCT, Clinical Professor, Emergency Medicine, Assistant Medical Director, Wright State University/Boonshoft School of Medicine, OneFifteen, Dayton, OH
Camille Broussard Robinson, MD, MPH
Assistant Professor of Pediatrics
Johns Hopkins University School of Medicine
Dr. Camille Broussard Robinson is an Assistant Professor of Pediatrics at the Johns Hopkins University School of Medicine in the Division of Adolescent & Young Adult Medicine. She is a public health-trained and board-certified Pediatrics, Adolescent Medicine, and Addiction Medicine specialist. She provides primary care and subspecialty consultative care to adolescents and young adults in the Center for Adolescent and Young Adult Health at Johns Hopkins Harriet Lane Clinic. Additionally, she provides subspecialty care for adolescents and young adults with Chronic Fatigue Syndrome, Postural Orthostatic Tachycardia Syndrome (POTS), and Long COVID in the Johns Hopkins Children’s Center Chronic Fatigue Clinic. As a clinician-scientist, her focus has been on the equitable care of underserved, medically and socially complex adolescent and young adult populations.
Dr. Broussard Robinson serves in several leadership roles including as associate director for the Adolescent Medicine fellowship program at Johns Hopkins and as Director of Research for the Chronic Fatigue Program at Johns Hopkins Children’s Center. She is also committed to the provision of trauma- and resiliency-informed, structurally competent care of adolescents and young adults and is involved in undergraduate, graduate, and continuing medical education in this area.
Dr. Broussard Robinson earned her medical degree from the University of California, San Francisco and an MPH from the University of California, Berkeley. She then completed a residency in Pediatrics, fellowship in Adolescent Medicine, and training in Addiction Medicine at the Johns Hopkins University School of Medicine.
Jordan Davidson
Communications and Legislative Affairs Officer
Smart Approaches to Marijuana (SAM)
Jordan Davidson serves as SAM’s Communications and Legislative Affairs Officer. When he was 17 years old, Jordan entered long-term addiction recovery after struggling with cannabis use disorder. Prior to joining SAM, Jordan worked in Connecticut politics at the state and federal level. At SAM, Jordan is a principal legislative staffer managing federal policy on Capitol Hill. Jordan helped shepherd the passage of the Medical Marijuana and Cannabidiol Research Expansion Act, the first-ever marijuana reform bill signed into law. He has also led the successful efforts to defeat Congressional passage of the MORE, States Reform, Cannabis Administration and Opportunity, and SAFE Banking Acts. Since he joined SAM in 2019, Jordan has specialized in youth outreach and substance abuse prevention. He has been invited as a guest speaker by organizations and members of Congress across the country. Jordan has a degree in Political Science from American University in Washington, D.C.
Robert L. DuPont, MD
President; Clinical Professor of Psychiatry
Institute for Behavior and Health; Georgetown University School of Medicine
For 50 years, Robert L. DuPont, MD has been a leader in substance use disorder treatment and prevention. He was the first Director of the U.S. National Institute on Drug Abuse (1973-1978) and the second White House Drug Chief (1973-1977). From 1968-1970 he was Director of Community Services for the District of Columbia Department of Corrections. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. In 1978 he became the founding President of the Institute for Behavior and Health, Inc., a non-profit research and policy organization that identifies and promotes powerful new ideas to reduce drug use and addiction. A graduate of Emory University, Dr. DuPont received an MD degree in 1963 from the Harvard Medical School. He completed his psychiatric training at Harvard and the National Institutes of Health in Bethesda, Maryland. Dr. DuPont has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. His most recent book is Chemical Slavery: Understanding Addiction and Stopping the Drug Epidemic.
Leslie R. Dye, MD, FACMT, FASAM, FACCT
Clinical Professor, Emergency Medicine, Assistant Medical Director
Wright State University/Boonshoft School of Medicine, OneFifteen
Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.
Ashley Haynes, MD, FACEP
Medical Toxicologist, Addiction Medicine Specialist
Ascension Via Christi Hospitals
Dr. Ashley Haynes completed her medical training at the University of Kansas, followed by a combined emergency-internal medicine training program at East Carolina University. She completed a toxicology fellowship at University of Texas Southwestern in 2016, remaining as faculty for a few years after while engaging in a faculty development project in addiction medicine. She moved to Kansas in 2019 and now provides bedside toxicology and addiction medicine consultations at Ascension Via Christi hospitals in Wichita and periodically provides on-call support for the Kansas Poison Control Center. Additionally, she is a program physician for an outpatient addiction treatment center, and provides medication assisted therapy services to an inpatient residential treatment facility.
Kevin Wenzel, PhD
Psychologist and Director of Research
Maryland Treatment Centers, Mountain Manor Treatment Center
Kevin Wenzel, PhD is a clinical psychologist and the director of research at Maryland Treatment Centers. There, he oversees a portfolio of clinical research related to substance use disorder. Dr. Wenzel has served as a principal or co-investigator on a number of NIH-funded clinical trials related to the treatment of opioid use disorder with a special focus on initiation and retention on relapse prevention medications, especially among young adults. In addition to his primary research endeavors, he oversees a clinical training program for psychology students at MTC and provides regular trainings for clinical staff.
Registration Rates
Registration includes:
- Access to the in-person event on April 11, 2024
- Access to the on-demand recordings for 90 days after the event
- Access to the Speaker slides
- Downloadable Certificate of Attendance
ACMT Member Rates Early-Bird Expires: Feb 20, 2024
Regular Rate Begins: Feb 21, 2024
Member Tier I: Full, Affiliate, International, Emeritus$250 $300
Member Tier II: Fellows$200 $250
Member Tier III: Residents, International - Developing Country
$125$175
Member IV: Medical Students
$100$150 Non-Member Rates Early-Bird Expires: Feb 20, 2024
Regular Rate Begins: Feb 21, 2024
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"
$350$400
Non-member Tier II: Fellows, SPIs, Nurses, etc.
$250$300
Non-member Tier III: Educators & Emergency Responders
$175$225
Non-member IV: Residents & Students
$150$200 Early-Bird Rate
Early-bird rates expire at midnight on FEBRUARY 20, 2024. Fees increase to the Regular Rate after this date, no exceptions.
ACMT Membership
ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership
Continuing Education
Continuing Education credit for this activity is available for an additional fee and is provided by AKH Inc., Advancing Knowledge in Healthcare. The activity is accredited for both live and enduring participation for the following:
- Physicians (Continuing Medical Education)
- Pharmacists (Continuing Pharmacy Education)
- Nurses (Continuing Nursing Education)
Cancellation Policy
Event registration cancellations received on or before February 25, 2024 (2/25/24) will receive a full refund less a 8% processing fee. Cancellations received between February 26, 2024 and March 26, 2024 (2/26/24-3/26/24) will receive a 50% refund. Cancellations made on or after March 27, 2024 (3/27/24) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.
All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Questions?
Write to: events@acmt.net
Continuing Education
Continuing Education credit for this activity will be provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
CME, CPE, and CNE Continuing Education credits are pending for this activity. It is expected that learners will receive up to 5.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
Venue Info
The 2024 ACMT Annual Scientific Meeting & Symposia will take place at the Omni Shoreham Hotel in Washington, DC.
Omni Shoreham Hotel
2500 Calvert St NW
Washington, DC 20008
Booking Link
ACMT has secured a discounted rate for attendees of our 2024 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Exclusive hotel rate expires: March 18, 2024
Explore DC
The landmark Omni Shoreham Hotel is located in Washington D.C.’s premier "Woodley" residential neighborhood. An icon among hotels in Washington, D.C., the Omni Shoreham Hotel has hosted presidents, world leaders and inaugural balls since its inception in the 1930s. Hotel amenities include a heated resort pool, relaxation gardens, a state-of-the art fitness center, and a massage therapy spa. The city’s most popular attractions are also nearby - including the National Zoo, the White House, the United States Capitol and the National Mall.
-
Register
- Early bird pricing available!
- Non-member - Tier I - $350
- Non-member - Tier II - $250
- Non-member - Tier III - $175
- Non-member - Tier IV - $150
- Member - Tier I - $250
- Member - Tier II - $200
- Member - Tier III - $125
- Member - Tier IV - $100
- Regular Price after 02/20/2024 11:59 PM
- Non-member - Tier I - $400
- Non-member - Tier II - $300
- Non-member - Tier III - $225
- Non-member - Tier IV - $200
- Member - Tier I - $300
- Member - Tier II - $250
- Member - Tier III - $175
- Member - Tier IV - $150
- More Information
-
Contains 1 Component(s) Includes a Live In-Person Event on 04/10/2024 at 11:45 AM (EDT)
April 10, 2024
2024 AACT Symposium | Antidote Shortages: Impact & Response
April 10, 2024
Omni Shoreham Hotel, Washington, DCJoin the American Academy of Clinical Toxicology (AACT) and ACMT on Wednesday, April 10, 2024 for a Symposium on "Antidote Shortages: Impact & Response." This half-day symposium gathers experts, researchers, healthcare professionals, and policymakers committed to addressing the critical issue of antidote shortages in our healthcare system. Attendees will engage in insightful discussions on the root causes and far-reaching consequences of these shortages, examining their effects on patient care, healthcare economics, and public health. Furthermore, the symposium will spotlight cutting-edge solutions and collaborative approaches aimed at mitigating these shortages, fostering resilience in healthcare systems, and ensuring timely access to life-saving antidotes. Together, participants will work towards building a more robust and responsive healthcare infrastructure that can effectively combat antidote shortages and safeguard patient well-being.
AACT Member Discount
AACT Members are eligible to receive the same registration rate as ACMT Members for this activity. Just enter the following code at checkout -- a $50 savings! Discount code: AACTAgenda coming soon!
Continuing Education
Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person or watch them on-demand after the event.
Book Hotel
ACMT has secured a discounted rate at the Omni Shoreham Hotel in Washington, DC for attendees of our 2024 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Questions?
Please write to ACMT at events@acmt.net
Registration Rates
Registration includes:
- Access to the in-person event on April 10, 2024
- Access to the on-demand recordings for 90 days after the event
- Access to the Speaker slides
- Downloadable Certificate of Attendance
ACMT Member Rates Early-Bird Expires: Feb 20, 2024
Regular Rate Begins: Feb 21, 2024
Member Tier I: Full, Affiliate, International, Emeritus$175 $225
Member Tier II: Fellows$125 $175
Member Tier III: Residents, International - Developing Country
$75$125
Member IV: Medical Students
$50$100 Non-Member Rates Early-Bird Expires: Feb 20, 2024
Regular Rate Begins: Feb 21, 2024
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"
$225$275
Non-member Tier II: Fellows, SPIs, Nurses, etc.
$175$225
Non-member Tier III: Educators & Emergency Responders
$125$175
Non-member IV: Residents & Students
$100$150 Early-Bird Rate
Early-bird rates expire at midnight on FEBRUARY 20, 2024. Fees increase to the Regular Rate after this date, no exceptions.
AACT Member Discount
AACT Members (who are not already ACMT Members) are eligible for a $50 discount! Enter the following code at checkout: AACT
Continuing Education
Continuing Education credit for this activity is available for an additional fee and is provided by AKH Inc., Advancing Knowledge in Healthcare. The activity is accredited for both live and enduring participation for the following:
- Physicians (Continuing Medical Education)
- Pharmacists (Continuing Pharmacy Education)
- Nurses (Continuing Nursing Education)
Cancellation Policy
Event registration cancellations received on or before February 25, 2024 (2/25/24) will receive a full refund less a 8% processing fee. Cancellations received between February 26, 2024 and March 26, 2024 (2/26/24-3/26/24) will receive a 50% refund. Cancellations made on or after March 27, 2024 (3/27/24) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.
All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Questions?
Write to: events@acmt.net
Continuing Education
Continuing Education credit for this activity will be provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
CME, CPE, and CNE Continuing Education credits are pending for this activity. It is expected that learners will receive up to 4.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
Venue Info
The 2024 ACMT Annual Scientific Meeting & Symposia will take place at the Omni Shoreham Hotel in Washington, DC.
Omni Shoreham Hotel
2500 Calvert St NW
Washington, DC 20008
Booking Link
ACMT has secured a discounted rate for attendees of our 2024 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Exclusive hotel rate expires: March 18, 2024
Explore DC
The landmark Omni Shoreham Hotel is located in Washington D.C.’s premier "Woodley" residential neighborhood. An icon among hotels in Washington, D.C., the Omni Shoreham Hotel has hosted presidents, world leaders and inaugural balls since its inception in the 1930s. Hotel amenities include a heated resort pool, relaxation gardens, a state-of-the art fitness center, and a massage therapy spa. The city’s most popular attractions are also nearby - including the National Zoo, the White House, the United States Capitol and the National Mall.
-
Register
- Early bird pricing available!
- Non-member - Tier I - $225
- Non-member - Tier II - $175
- Non-member - Tier III - $125
- Non-member - Tier IV - $100
- Member - Tier I - $175
- Member - Tier II - $125
- Member - Tier III - $75
- Member - Tier IV - $50
- Regular Price after 02/20/2024 11:59 PM
- Non-member - Tier I - $275
- Non-member - Tier II - $225
- Non-member - Tier III - $175
- Non-member - Tier IV - $150
- Member - Tier I - $225
- Member - Tier II - $175
- Member - Tier III - $125
- Member - Tier IV - $100
- More Information
-
Contains 4 Product(s)
5 Activity Package
In partnership with:
Overview
The American College of Medical Toxicology (ACMT) is delighted to announce that it has been awarded with a Eugene Washington Patient Engagement Grant from the Patient-Centered Outcomes Research Institute (PCORI). Titled "Confronting the Overdose Epidemic by Engaging Patients to Improve Medical Toxicology Research," this project aims to develop a connection between patients and medical toxicology researchers to advance patient-centered outcomes research on intentional overdoses. The award offers a series of virtual activities that bring together patients who have personally experienced intentional overdoses and welcomes participation from all medical toxicology researchers.
Project Activities
Spanning five activities, this project kicks off on October 11th and 13th when medical toxicology researchers will embark on a comprehensive two-part Town Hall Research Training led by the Patient Engagement Studio, equipping them with the skills to effectively engage patients in research development, design, and dissemination. Then, on October 26th and November 29th, Interactive Sessions 1 & 2 will convene patients, stakeholders, and interested medical toxicology researchers. During these sessions, research priorities for medical toxicology research on intentional overdoses will be established, followed by the development of an engagement strategy guide for medical toxicology researchers. The final culmination of this groundbreaking project will take place on January 31, 2024 with a Follow-Up Meeting, which will serve as a platform to discuss the future of intentional overdose research in the field of medical toxicology. With a particular focus on strategies for sustainability, this session will delve into the crucial aspect of maintaining patient engagement throughout the entire research process.
Project Objectives
- Educate medical toxicology researchers and patients on PCOR/CER collaborations for intentional overdoses
- Develop a collaborative partnership of patient experts and stakeholders to engage in intentional overdose focused PCOR/CER
- Create and develop research priorities for PCOR/CER on intentional overdoses
Project Goals
This award underscores ACMT's unwavering commitment to patient engagement and our dedication to enhancing the field of medical toxicology through collaborative research initiatives. Through collective efforts, ACMT and the project participants aim to create a lasting impact on intentional overdose research, ultimately leading to improved patient-centered outcomes and a brighter future for those affected by this critical public health issue.
Registration Rates
ACMT Member
FreeInterested in becoming an ACMT Member? Contact our Membership Manager, Lauren Turner, at membership@acmt.net. Learn more at: www.acmt.net/membership
Registration includes:
- Access to all 5 live virtual events
- Access to the on-demand recording after the events
Questions?
For any questions, please email us at events@acmt.net.
Schedule
October 11, 2023 | Town Hall Research Training, Pt 1
October 13, 2023 | Town Hall Research Training, Pt 2
October 26, 2023 | Interactive Session 1
November 29, 2023 | Interactive Session 2
January 31, 2024 | Follow-Up Meeting
Instructions
Once you have completed your registration:
- Click the View Button on the activity you want to view.
- Click on the Contents tab on the day of live event. This is where you will be able view the Zoom link for the course.
- Watch live event. You can use the Zoom link in the Learning Center to leave and enter the webinar during event.
Hardware/Software Requirements
Computer or Other Internet-Enabled Device; Internet Connection; Browser.
Materials
None.
Prerequisites
None.
Format
This activity is Web-based/Web on Demand.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.
-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Contains 1 Component(s) Includes a Live Web Event on 01/31/2024 at 1:00 PM (EST)
The final follow-up meeting on the future of intentional overdose research in medical toxicology
Overview
This final follow-up meeting will discuss the future of intentional overdose research in medical toxicology, including strategies for sustainability of patient engagement throughout the research process.
Project Objectives
- Educate medical toxicology researchers and patients on PCOR/CER collaborations for intentional overdoses
- Develop a collaborative partnership of patient experts and stakeholders to engage in intentional overdose focused PCOR/CER
- Create and develop research priorities for PCOR/CER on intentional overdoses
About the Project
Titled "Confronting the Overdose Epidemic by Engaging Patients to Improve Medical Toxicology Research," this project aims to develop a connection between patients and medical toxicology researchers to advance patient-centered outcomes research on intentional overdoses. It consists of 5 separate, live activities. Activities will consist of virtual one-on-one meetings with patients and the project lead; listening and interactive virtual meetings with patient experts, stakeholders and researchers; and virtual training sessions on how to collaborate toward PCOR/CER for intentional overdoses.
- Town Hall Research Training Part 1
- Town Hall Research Training Part 2
- Interactive Session 1
- Interactive Session 2
Attendees can register for each activity separately as meets their needs or interest, or sign up for the 5-activity package.
Registration Rates
ACMT Member
Free
Non-member
FreeInterested in becoming an ACMT Member? Contact our Membership Manager, Lauren Turner, at membership@acmt.net. Learn more at: www.acmt.net/membership
Registration includes:
- Access to the live virtual event
- Access to the on-demand recording after the event
Questions?
For any questions, please email us at events@acmt.net.
Instructions
Once you have completed your registration:
- Click the View Button on the activity you want to view.
- Click on the Contents tab on the day of live event. This is where you will be able view the Zoom link for the course.
- Watch live event. You can use the Zoom link in the Learning Center to leave and enter the webinar during event.
Hardware/Software Requirements
Computer or Other Internet-Enabled Device; Internet Connection; Browser.
Materials
None.
Prerequisites
None.
Format
This activity is Web-based/Web on Demand.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Contains 4 Component(s) Includes a Live Web Event on 12/21/2023 at 1:00 PM (EST)
Cases to be announced.
Cases
Coming soon!
Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ
About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.
This webinar is for ACMT members only.
Lewis Nelson, MD, MBA, FACMT, FASAM
Chair of Emergency Medicine
Rutgers New Jersey Medical School
Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.
Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Register
-
Contains 3 Component(s) Includes a Live Web Event on 12/15/2023 at 9:45 AM (EST)
Live Virtual Event - Friday December 15, 2023
In partnership with:
Overview
2023 ACMT Seminar in Forensic Toxicology Day 2 - Living in a PolyDrug World - Lab and Medical Complexities: Bridging Medicine and Law for a Safer Tomorrow!
Join us for an enlightening one-day virtual event on Polydrug Exposures, where the worlds of medicine and law intersect to shed light on this complex topic!
The American College of Medical Toxicology (ACMT) and the Center for Forensic Science Research and Education (CFSRE) proudly present a groundbreaking seminar that delves into the medical-legal aspects surrounding polydrug exposures. This exclusive virtual on December 15, 2023 will bring together leading experts, researchers, and professionals to explore the latest advancements and critical insights in this rapidly evolving field.
Lecture Highlights:
During the lecture, the speakers will:
- Demonstrate a comprehensive understanding of the complexities and challenges in forensic toxicology related to polydrug use, including community drug checking, toxicology testing, and drug overdose surveillance.
- Evaluate the strengths and limitations of different toxicology testing methods and their applications in forensic investigations, considering the evolving drug landscape and the need for accurate and reliable results.
- Analyze the impact of limited resources on addressing the upsurge in opioid and polydrug deaths, and propose effective strategies to confront these challenges while prioritizing public health and safety.
- Assess the role of medical examiners and coroners in drug overdose surveillance and information sharing, emphasizing the importance of accurate data collection in reports to inform public health interventions and policies.
- Apply critical thinking and analytical skills to interpret complex cases involving multiple drugs, integrating perspectives from forensic toxicologists, medical examiners, and clinical toxicologists to ensure comprehensive understanding and effective collaboration in forensic investigations.
Secure your place now and unlock a wealth of knowledge in this rapidly evolving field. Register today and be part of this game-changing event!
Polydrug Exposures Virtual Event: Bridging Medicine and Law for a Safer Tomorrow!
Recommended By:
Target Audience
The course will be tailored to the interests of physicians and professionals of numerous specialties, including medical toxicology, forensics and laboratory medicine, addiction medicine, and the legal community.
Learner Objectives
After attending the event, participants should be able to:
- Describe the complexities and challenges of forensic and medical toxicology in cases involving polydrugs.
Preliminary Agenda | December 15, 2023
9:45 - 10:00 AM ET | Opening Remarks
10:00 - 10:30 AM ET
Community Drug Checking in a Polydrug World: Perspective from Field Harm Reduction Specialists
Karen McDonald, MPPAL, PMP, Lead, Toronto’s Drug Checking Service, Research Program Manager, Centre on Drug Policy Evaluation, St. Michael’s Hospital, Toronto, Canada10:30 - 11:00 AM ET
Understanding the Strengths and Limitations of Toxicology Testing
James Gill, MD, Chief Medical Examiner, Office of the Chief Medical Examiner, Farmington, CT11:00 - 11:30 AM ET
Confronting an Upsurge in Opioid and Poly-Drug Deaths With Limited Resources
Jennie V. Duval, MD, Chief Medical Examiner, Office of the Chief Medical Examiner, Concord, NH11:30 - 12:00 PM ET
Perspective of Clinical Toxicologist on Polydrug World and Treatment Strategies
Joseph L. D’Orazio, MD, FAAEM, FACMT, FASAM, FCPP, Department of Emergency Medicine, Division of Toxicology and Addiction Medicine, Cooper Center for Healing, Camden, NJ
12:00 - 12:30 PM ET | Break - 30 min
12:30 - 1:00 PM ET
NPS - Landscape, Trends, and Current Polydrug Connections
Alex Krotulski, PhD, Associate Director of Toxicology & Chemistry, The Center for Forensic Science Research and Education, Willow Grove, PA1:00 - 1:30 PM ET
Drug Delivery Homicide - History, Survey of State Laws, and Discussion About Legal Process
MJ Menendez, JD, Senior Fellow and General Counsel, Center for Forensic Science Research and Education, Willow Grove, PA1:30 - 2:00 PM ET
Drug Delivery Homicide Case Reports (with Focus on Fentanyl Drug Combinations - Benzodiazepines, Xylazine, etc.)
Barry Logan, PhD, F-ABFT, Executive Director, Center for Forensic Science Research and Education, Sr. VP and Chief Scientist, Forensic Sciences, NMS Labs, Willow Grove, PA2:00 - 2:30 PM ET
Xylazine - Everything to Know About Fentanyl Adulteration
Sherri Kacinko, Ph.D., F-ABFT, Forensic Toxicologist , NMS Labs, Horsham, PA
2:30 - 3:00 PM ET | Break - 30 min
3:00 - 3:30 PM ET
Clinical Toxicology Testing - Methodology, Advancements, and Understanding
Andrew Holt, PharmD, Clinical Pharmacist & Fellowship Director, Aegis Sciences Corporation, Nashville, TN3:30 - 4:00 PM ET
When Clinical Samples and Results Become of Forensic & Legal Interest
Donna Papsun, MS, D-ABFT-FT, Forensic Toxicologist & Business Scientist, NMS Labs, Horsham, PA
Charles McKay, MD, FACMT, Associate Medical Director, CT Poison Control Center, University of Connecticut School of Medicine, Farmington, CT4:00 - 5:00 PM ET
Roundtable - Interpretation of Cases Involving Multiple DrugsPanel
James Gill, MD, Chief Medical Examiner, Office of the Chief Medical Examiner, Farmington, CT
Donna Papsun, MS, D-ABFT-FT, Forensic Toxicologist & Business Scientist, NMS Labs, Horsham, PA
Paul Wax, MD, FACMT, Executive Director, American College of Medical Toxicology, Phoenix, AZModerator
Alex Krotulski, PhD, Associate Director of Toxicology & Chemistry, The Center for Forensic Science Research and Education, Willow Grove, PARegistration Rates
Registration includes:
- Access to the live virtual event on December 15, 2023
- Access to the on-demand recording for one year after event
- Access to the Speaker slides
- Downloadable Certificate of Attendance
Member Rates
Member Tier I: Full, Affiliate, International, Emeritus
$200
Member Tier II: Fellows
$175
Member Tier III: Residents, International - Developing Country
$150
Member IV: Medical Students
$125Non-Member Rates
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"
$250
Non-member Tier II: Fellows, SPIs, Nurses, etc.
$225
Non-member Tier III: Educators & Emergency Responders
$200
Non-member IV: Residents & Students
$175Interested in becoming an ACMT Member? Contact our Membership Manager, Lauren Turner, at membership@acmt.net. Learn more at: www.acmt.net/membership
A member
Interested in Continuing Education?
Continuing Education credit for this activity is provided by Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.
Purchase Continuing Education here!
Package Rates
Sign up for the both days of the 2023 ACMT Seminar in Forensic Toxicology and save $50!
Refunds and Cancellations
- Cancellations made 15 days or more in advance of the event date will receive a full refund less a 6% processing fee.
- Cancellations made within 14 days of the event date will not receive a refund.
All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance (family emergency, for example) and must be submitted in writing to events@acmt.net. For these instances, the full registration fee, minus a 6% processing fee, will be refunded. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Questions?
For any questions, please email us at events@acmt.net.
Instructions
Once you have completed your registration:
- Click on the Contents tab on the day of live event. This is where you will be able view the Zoom link for the course as well as the event survey and downloadable Certificate of Attendance.
- Watch live event. You can use the Zoom link in the Learning Center to leave and enter the webinar during event.
- Complete the Survey. If you are completing CE or would like your Certificate of Attendance, completion of this survey is required.
- Download the Certificate of Attendance. This is only a record that you have attended the course.
In order to receive and download your CE certificate, please go to your CE product to complete the required steps and claim your CE certificate.
Hardware/Software Requirements
Computer or Other Internet-Enabled Device; Internet Connection; Browser.
Materials
None.
Prerequisites
None.
Format
This event is a live Webinar.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.
If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.
Joseph L. D’Orazio, MD, FAAEM, FACMT, FASAM, FCPP
Toxicology Consultant
Division of Toxicology and Addiction Medicine, Cooper Center for Healing
Dr. Joseph D'Orazio is board certified in Emergency Medicine, Medical Toxicology, and Addiction Medicine. He practices Medical Toxicology and Addiction Medicine for the Cooper Center for Healing at Cooper University Hospital in Camden, NJ. Dr. D’Orazio cares for patients who are admitted to Cooper University Hospital through the addiction medicine and toxicology inpatient consultative service and through the Cooper Center for Healing outpatient offices. Dr. D’Orazio is a medical toxicologist for the Poison Control Center at Children’s Hospital of Philadelphia and is regarded as a regional expert in substance use and substance use disorder treatment in the Philadelphia area.
Jennie V. Duval, MD
Chief Medical Examiner
Office of the Chief Medical Examiner
Jennie Duval was appointed Chief Medical Examiner for the State of New Hampshire on October 1, 2017 after serving as the Deputy Chief Medical Examiner for over 15 years. She earned her undergraduate degree from the University of New Hampshire and her medical degree from McGill University, Montreal, Quebec. She completed pathology residency training at the University of Massachusetts Medical Center and forensic pathology fellowship training at the Office of the Chief Medical Examiner in Boston. She teaches pathology and forensic pathology to medical students, physician assistant students and pathology residents at various institutions in New Hampshire. In addition, she has published several journal articles, presented numerous scientific papers at national professional society meetings and lectures frequently on various topics in forensic pathology including drug related deaths. During her career she has performed over 6,600 autopsies including over 1,700 drug related deaths.
James Gill, MD
Chief Medical Examiner
Office of the Chief Medical Examiner
James R. Gill MD is the Chief Medical Examiner of Connecticut, past Chair of the Forensic Pathology Committee of the College of American Pathologists (CAP), and a past President of the National Association of Medical Examiners (NAME). He has faculty medical appointments at Yale, University of Connecticut, and Quinnipiac University. He did his pathology training at Yale and Memorial Sloan-Kettering Cancer Center and his forensic pathology fellowship at the New York City Office of Chief Medical Examiner. Prior to Connecticut, he was the Deputy Chief Medical Examiner for Bronx County. He has testified over 450 times in criminal and civil matters in State and Federal courts and has published over 100 scientific articles and book chapters, and two books on a variety of forensic pathology topics. He has particular interests in public health including drug intoxication deaths, infectious disease, fatal complications of therapy, and proper death certification.
Andrew Holt, PharmD
Clinical Pharmacist & Fellowship Director
Aegis Sciences Corporation
Dr. Andrew Holt received his Doctor of Pharmacy degree from the University of Tennessee Health Science Center and is licensed to practice in multiple states. Prior to joining Aegis, Dr. Holt worked for the Tennessee Board of Pharmacy as Executive Director and was Director of Tennessee’s Prescription Drug Monitoring Program. He holds additional certifications in medical affairs, pharmacogenomics, and drugs in sport. Dr. Holt is an assistant professor for the Department of Clinical Pharmacy and Translational Science at the University of Tennessee College of Pharmacy, serves as a preceptor for six colleges of pharmacy and is a co-Director of the post-doctoral Fellowship Program, a collaboration with Belmont College of Pharmacy. One of his primary interests is the surveillance and detection of novel psychoactive substances and their role in overdoses.
Sherri Kacinko, PhD, F-ABFT
Forensic Toxicologist
NMS Labs
Dr. Sherri Kacinko is a senior toxicologist at NMS Labs in Horsham, PA. She earned her Ph.D. in toxicology from the University of Maryland – Baltimore. She is also adjunct faculty in the chemistry and forensic science departments at Arcadia University and serves as an Instructor at the Center for Forensic Science Research & Education. In her teaching roles, Dr. Kacinko lectures in pharmacology, postmortem toxicology, and human performance toxicology courses.
Dr. Kacinko is a fellow of the American Board of Forensic Toxicology (ABFT) and is a member of the Society of Forensic Toxicologists, the International Association of Forensic Toxicologists, and the American Academy of Forensic Sciences. She was presented with the American Academy of Forensic Sciences Toxicology Section Irving Sunshine Award in recognition of early career research and served as the program chair, secretary and chair of the AAFS toxicology section.
Current research interests include the identification and quantification of novel psychoactive substances and esoteric drugs including synthetic cannabinoids, stimulants, hallucinogens, opioids and benzodiazepines in biological fluids and their toxicological impact. Dr. Kacinko also uses data analytics to monitoring drug use trends on a local and national level.
Alex Krotulski, PhD
Associate Director of Toxicology & Chemistry
The Center for Forensic Science Research and Education
Dr. Alex Krotulski serves as an Associate Director at CFSRE working in the areas of forensic toxicology and forensic chemistry and is the Program Manager for NPS Discovery. Dr. Krotulski holds faculty appointment and serves as the Assistance Program Director for the Thomas Jefferson University Master of Science in Forensic Toxicology (MSFT) program and was recently appointed as an Associate Editor for the Journal of Analytical Toxicology. Dr. Krotulski received his Doctor of Philosophy degree in Analytical Chemistry from Temple University in 2019 following receipt of his Master of Science degree in Forensic Science from Arcadia University in 2015 and Bachelor of Science in Chemistry from Loyola University New Orleans in 2013.
Barry Logan, PhD, F-ABFT
Executive Director, Sr. VP & Chief Scientist Forensic Sciences
Center for Forensic Science Research and Education & NMS Labs
Dr. Barry Logan is Sr. vice president of Forensic Sciences, and Chief Scientist for NMS Labs. He is also Executive Director at the non-profit Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in Willow Grove, Pennsylvania.
Dr. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over 190 publications in forensic toxicology and chemistry, including work on the effects of illicit and prescription drugs on drivers, and drug caused and related death. His current research priorities are focused on new drug surveillance and trends, the polydrug crisis, and the analytical and interpretive toxicology and chemistry of novel psychoactive substances, founding www.NPSDiscovery.org in 2018.
Dr. Logan’s has academic appointments at Indiana University, Arcadia University and Thomas Jefferson University in Philadelphia. He serves on the Advisory Board for NIDA’s National Drug Early Warning System (NDEWS). In recognition of his work and contributions, Dr. Logan received TIAFT’s Alan Curry Award in 2022, and is a past President of the American Academy of Forensic Sciences (AAFS).
Karen McDonald, MPPAL, PMP
Lead
Toronto’s Drug Checking Service
Karen has over fifteen years of public sector experience, where she has informed public policy and contributed to health systems change. She has spent the past five years leading the design and implementation of Toronto’s Drug Checking Service, and is now responsible for the program’s continuation and expansion across Ontario. Karen has received international recognition as a leader in drug checking service provision and unregulated drug market surveillance and education.
Charles McKay, MD, FACMT
Associate Medical Director
CT Poison Control Center, University of Connecticut School of Medicine
Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.
MJ Menendez, JD
Senior Fellow and General Counsel
Center for Forensic Science Research and Education
M.J. Menendez, J.D. is Senior Fellow and General Counsel for the Center for Forensic Science Research and Education in Willow Grove, Pennsylvania. M.J. served on detail as the Department of Justice’s Organized Crime Drug Enforcement Task Forces Heroin, Opioid and Fentanyl Special Projects Coordinator from 2015 to 2019. M.J. served 13 years as an Assistant U.S. Attorney in Colorado, 10 years as a state prosecutor in Jefferson County, Colorado, and 3 years as a state court judge in Jefferson County, Colorado. M.J. is passionate about achieving well-resourced excellence in medicolegal death investigations, and she proudly works with the National Association of Medical Examiners as Chair of Strategic Planning and Chair of the Forensic Pathology Shortage / Workforce Remediation Subcommittee.
Donna Papsun, MS, D-ABFT-FT
Forensic Toxicologist & Business Scientist
MS Labs
Donna Papsun is a forensic toxicologist and business scientist with NMS Labs in Horsham, PA. She has dual Bachelor of Science degrees in Chemistry and Forensic & Investigative Science and a Master of Science degree in Pharmacology. She is also certified as a Diplomate in Forensic Toxicology through the American Board of Forensic Toxicology and is a member of both the Society of Forensic Toxicologists (SOFT) and the American Academy of Forensic Sciences (AAFS).
Ms. Papsun has been with NMS Labs since 2008, first as a bench analyst before promotion to toxicologist in 2012. Ms. Papsun’s main area of interest is novel psychoactive substances or NPS. As one of the two leaders of NMS’s NPS strategy team, she continuously works to help maintain NMS’s leadership in identifying the newest trends in the changing landscape of the designer drug market and developing tests for their detection in forensic toxicology casework. Ms. Papsun also serves in a secondary role as a business scientist, working to align the technical and scientific expertise of NMS Labs with commercial efforts.
Paul M. Wax, MD, FACMT
Executive Director
American College of Medical Toxicology (ACMT)
Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.
-
Register
- Non-member - Tier I - $250
- Non-member - Tier II - $225
- Non-member - Tier III - $200
- Non-member - Tier IV - $175
- Member - Tier I - $200
- Member - Tier II - $175
- Member - Tier III - $150
- Member - Tier IV - $125
- More Information
-
Contains 2 Product(s)
Live Virtual Event December 14-15, 2023
The American College of Medical Toxicology (ACMT) and the Center for Forensic Science Research and Education (CFSRE) invite you to register for a two-day virtual educational event featuring some of the top professionals in forensic science and medicine, harm reduction, and the legal and law enforcement fields from across the U.S., Canada, and Europe.
Expert faculty will review cannabis and alternative cannabinoid impairment, and assess new research on medical legal death investigations involving polydrug exposures including fentanyl, xylazine, benzodiazepines, and more.
Join us for our 2-day virtual seminar broadcast live on December 14-15, 2023. Can't make the live event? No problem! Register now and access later on-demand at your convenience.
Purchase Continuing Medical Education Credit (CME)
By registering for this 2-day package you will enjoy a savings of $50 off the total cost.
If you prefer to register for just one day, please click on the links below:December 14, 2023: Cannabis and the Expanding World of Cannabinoids
December 15, 2023: Living in a Poly Drug World - Lab and Medical ComplexitiesRecommended By:
Target Audience
This virtual seminar is an essential event for professionals in the field, including
Emergency Physicians
Forensic Toxicologists
Legal Nurse Consultants
Analytical Chemists
Criminalists
Forensic Scientists
Medical Examiners
Medical Review Officers
Attorneys (including attorneys general)
Law Enforcement (Sheriff’s Office, Highway Patrol, Highway Safety, State Troopers and more)
Learning Objectives
After completing these two seminars, learners should be able to:
- Recognize the historical and legislative drivers of cannabis legalization and cannabinoids.
- Evaluate laboratory testing challenges and pharmacological mechanisms of cannabinoids.
- Describe the complexities and challenges of forensic and medical toxicology in cases involving polydrug exposures.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.
If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.
Registration Rates
Registration includes:
- Access to both live virtual events December 14-15, 2023
- Access to the on-demand recordings for one year after event
- Access to Speaker slides
- Access to Certificate of Attendance for both events
Member Rates
Member Tier I: Full, Affiliate, International, Emeritus
$350
Member Tier II: Fellows
$300
Member Tier III: Residents, International - Developing Country
$250
Member IV: Medical Students
$200Non-Member Rates
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"
$450
Non-member Tier II: Fellows, SPIs, Nurses, etc.
$400
Non-member Tier III: Educators & Emergency Responders
$350
Non-member IV: Residents & Students
$300Interested in becoming an ACMT Member? Contact our Membership Manager, Lauren Turner, at membership@acmt.net. Learn more at: www.acmt.net/membership
Continuing Education
Interested in Continuing Education? Continuing Education credit for this activity is provided by Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team. Click on the link below for additional information!
Purchase Continuing Education here!
Available Discounts
If you are a member of one of the following organizations, you may be eligible for a registration discount. Please reach out to us at events@acmt.net for a discount code:
- Society of Forensic Toxicologists, Inc (SOFT)
- Drugimpairment.com
Refunds and Cancellations
- Cancellations made 16 days or more in advance of the event date will receive a full refund less a 6% processing fee.
- Cancellations made within 15 days of the event date will not receive a refund.
All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance (family emergency, for example) and must be submitted in writing to events@acmt.net. For these instances, the full registration fee, minus a 6% processing fee, will be refunded. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Questions?
For any questions, please email us at events@acmt.net.
Thursday, December 14, 2023: Cannabis and the Expanding World of Cannabinoids
9:45 - 10:00 AM ET | Opening Remarks
10:00 - 10:30 AM ET
How Did We Get Here? Cannabis Legalization, the Farm Bill, Cannabinoid Analogues, & Chemistry
Glen P. Jackson, PhD, Professor of Forensic & Investigative Sciences, West Virginia University, Morgantown, WV10:30 - 11:00 AM ET
Challenges with Prosecuting Marijuana DUIs and other Legal Questions Post Legalization
Deena Ryerson, Sr. Assistant Attorney General, DUII Resource Prosecutor, Oregon Department of Justice, Salem, OR11:00 - 11:30 AM ET
Medical Toxicology Perspective on the Rise in Use and Adverse Events with Cannabinoid Products
Robert G. Hendrickson, MD, FACMT, FACEP, FAACT, Director, Emergency Medicine Toxicology Fellowship; Associate Medical Director, Oregon Poison Center; Professor of Emergency Medicine, School of Medicine, Oregon Health & Science University, Portland, OR11:30 - 12:00 PM ET
Analytical Perspectives and Challenges for Adoption of Cannabinoid Methodology
Ayako Chan-Hosokawa, MS, D-ABFT, Toxicology Team Manager & Forensic Toxicologist, NMS Labs, Horsham, PA
12:00 - 12:30 PM ET | Break - 30 min
12:30 - 1:00 PM ET
Acute vs Chronic Cannabinoid Use and Different Routes of Administration
Natalie Desrosiers, PhD, F-ABFT, Forensic Laboratory Team Leader, Services de toxicologie, Royal Canadian Mounted Police, Ottawa, Canada1:00 - 1:30 PM ET
Pharmacological Mechanism Underlying Driving Impairment
Jan Ramaekers, PhD, Professor of Psychopharmacology and Behavioral Toxicology, Maastricht University, Maastricht, The Netherlands1:30 - 2:00 PM ET
State-wide Oral Fluid Program and Courtroom Experiences
Curt E. Harper, Ph.D., F-ABFT, Chief Toxicologist, Alabama Department of Forensic Sciences, Hoover, AL2:00 - 2:30 PM ET
AFMES Experience with Semi-Synthetic Cannabinoids: Both Analytical & Interpretative
Erin L. Karschner, Ph.D., F-ABFT, Division of Forensic Toxicology, Armed Forces Medical Examiner System, Dover, DE
2:30 - 3:00 PM ET | Break - 30 min
3:00 - 3:30 PM ET
The Value of Different Pieces of Toxicology Data for Testimony
Bruce Goldberger, PhD, Chief, Division of Forensic Medicine, Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL3:30 - 4:00 PM ET
ASB Standards - From Scope of Testing to Testimony
Marc LeBeau, PhD, F-ABFT, Senior Forensic Scientist in the Scientific Analysis Section, FBI Laboratory, Quantico, VA4:00 - 5:00 PM ET
Roundtable & Case DiscussionsPanel
Erin L. Karschner, PhD, F-ABFT, Division of Forensic Toxicology, Armed Forces Medical Examiner System, Dover, DE
Ayako Chan-Hosokawa, MS, D-ABFT, Toxicology Team Manager & Forensic Toxicologist, NMS Labs, Horsham, PA
Robert G. Hendrickson, MD, FACMT, FACEP, FAACT, Director, Emergency Medicine Toxicology Fellowship; Associate Medical Director, Oregon Poison Center; Professor of Emergency Medicine, School of Medicine, Oregon Health & Science University, Portland, OR
Charles McKay, MD, FACMT, Associate Medical Director, CT Poison Control Center, University of Connecticut School of Medicine, Farmington, CTModerator
Donna Papsun, MS, D-ABFT-FT, Forensic Toxicologist & Business Scientist, NMS Labs, Horsham, PA
Friday, December 15, 2023: Living in a Poly Drug World - Lab and Medical Complexities
9:45 - 10:00 AM ET | Opening Remarks
10:00 - 10:30 AM ET
Community Drug Checking in a Polydrug World: Perspective from Field Harm Reduction Specialists
Karen McDonald, MPPAL, PMP, Lead, Toronto’s Drug Checking Service, Research Program Manager, Centre on Drug Policy Evaluation, St. Michael’s Hospital, Toronto, Canada10:30 - 11:00 AM ET
Understanding the Strengths and Limitations of Toxicology Testing
James Gill, MD, Chief Medical Examiner, Office of the Chief Medical Examiner, Farmington, CT11:00 - 11:30 AM ET
Confronting an Upsurge in Opioid and Poly-Drug Deaths With Limited Resources
Jennie V. Duval, MD, Chief Medical Examiner, Office of the Chief Medical Examiner, Concord, NH11:30 - 12:00 PM ET
Perspective of Clinical Toxicologist on Polydrug World and Treatment Strategies
Joseph L. D’Orazio, MD, FAAEM, FACMT, FASAM, FCPP, Department of Emergency Medicine, Division of Toxicology and Addiction Medicine, Cooper Center for Healing, Camden, NJ
12:00 - 12:30 PM ET | Break - 30 min
12:30 - 1:00 PM ET
NPS - Landscape, Trends, and Current Polydrug Connections
Alex Krotulski, PhD, Associate Director of Toxicology & Chemistry, The Center for Forensic Science Research and Education, Willow Grove, PA1:00 - 1:30 PM ET
Drug Delivery Homicide - History, Survey of State Laws, and Discussion About Legal Process
MJ Menendez, JD, Senior Fellow and General Counsel, Center for Forensic Science Research and Education, Willow Grove, PA1:30 - 2:00 PM ET
Drug Delivery Homicide Case Reports (with Focus on Fentanyl Drug Combinations - Benzodiazepines, Xylazine, etc.)
Barry Logan, PhD, F-ABFT, Executive Director, Center for Forensic Science Research and Education, Sr. VP and Chief Scientist, Forensic Sciences, NMS Labs, Willow Grove, PA2:00 - 2:30 PM ET
Xylazine - Everything to Know About Fentanyl Adulteration
Sherri Kacinko, Ph.D., F-ABFT, Forensic Toxicologist , NMS Labs, Horsham, PA
2:30 - 3:00 PM ET | Break - 30 min
3:00 - 3:30 PM ET
Clinical Toxicology Testing - Methodology, Advancements, and Understanding
Andrew Holt, PharmD, Clinical Pharmacist & Fellowship Director, Aegis Sciences Corporation, Nashville, TN3:30 - 4:00 PM ET
When Clinical Samples and Results Become of Forensic & Legal Interest
Donna Papsun, MS, D-ABFT-FT, Forensic Toxicologist & Business Scientist, NMS Labs, Horsham, PA
Charles McKay, MD, FACMT, Associate Medical Director, CT Poison Control Center, University of Connecticut School of Medicine, Farmington, CT4:00 - 5:00 PM ET
Roundtable - Interpretation of Cases Involving Multiple DrugsPanel
James Gill, MD, Chief Medical Examiner, Office of the Chief Medical Examiner, Farmington, CT
Donna Papsun, MS, D-ABFT-FT, Forensic Toxicologist & Business Scientist, NMS Labs, Horsham, PA
Paul Wax, MD, FACMT, Executive Director, American College of Medical Toxicology, Phoenix, AZModerator
Alex Krotulski, PhD, Associate Director of Toxicology & Chemistry, The Center for Forensic Science Research and Education, Willow Grove, PAThursday, December 14: " Cannabis and the Expanding World of Cannabinoids"
Speaker InformationAyako Chan-Hosokawa, MS, D-ABFT-FT
Toxicology Team Manager & Forensic Toxicologist
NMS Labs
Ayako (Aya) Chan-Hosokawa is a Forensic Toxicologist and Toxicology Team Manager with NMS Labs in Horsham, PA. She earned her Bachelor of Science in Chemistry from Stockton University and her Master of Science in Chemistry from the University of Minnesota. Ms. Chan-Hosokawa is also certified as a Diplomate through the American Board of Forensic Toxicology (ABFT) and is a member of the Society of Forensic Toxicologists (SOFT), the American Academy of Forensic Sciences (AAFS), the International Association of Forensic Toxicologists (TIAFT), International Council on Alcohol, Drugs and Traffic Safety (ICADT) and National Safety Council (NSC). She currently serves on the SOFT/AAFS Drugs and Driving Committee, the SOFT Finance Committee, and the AAFS Awards Committee.
Ms. Chan-Hosokawa has testified over 130 times in various jurisdictions (for both prosecution and defense) and routinely provides written expert opinion reports. She also serves as a faculty member for the Pennsylvania District Attorneys Institute (PDAI) for their annual training of prosecutors and investigators and was involved in the 2021 updates to the National Safety Council’s Alcohol, Drugs, & Impairment Division’s recommendations for drug testing in DUID cases. Her recent publications include Emergence of Delta-8 Tetrahydrocannabinol and 11-Year Study of Fentanyl in Driving under the Influence of Drugs Casework.
Natalie Desrosiers, PhD, F-ABFT
Forensic Laboratory Team Leader
Services de toxicologie, Royal Canadian Mounted Police
Bruce Goldberger, PhD
Chief, Division of Forensic Medicine
Department of Pathology, Immunology and Laboratory Medicine, University of Florida
Dr. Bruce Goldberger is a Professor in the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida in Gainesville. Dr. Goldberger is the Co-Investigator of the National Drug Early Warning System (NDEWS), a consultant for the Florida Department of Health and the Centers for Disease Control and Prevention, and a member of the White House Office of National Drug Control Policy Evolving and Emerging Threats Committee. Dr. Goldberger is the President of the American Board of Forensic Toxicology and the Editor-in-Chief of the Journal of Analytical Toxicology, the official journal of the Society of Forensic Toxicologists and The International Association of Forensic Toxicologists. Dr. Goldberger is prolific in research and publication in the areas of clinical, medical, and forensic toxicology, as well as in the medicolegal investigation of death including the certification of the cause and manner of death.
Curt E. Harper, Ph.D., F-ABFT
Chief Toxicologist
Alabama Department of Forensic Sciences
Dr. Curt E. Harper has over 15 years of experience as a Forensic Toxicologist. He was appointed Chief Toxicologist for the Alabama Department of Forensic Sciences (ADFS) in 2012. As Chief Toxicologist, he oversees technical operations, method development and validation, and the quality assurance/quality control program, manages productivity, serves as training coordinator, and develops and maintains standard operating procedures. Dr. Harper has a Ph.D. in Pharmacology and Toxicology and a Master’s of Science in Forensic Science from the University of Alabama at Birmingham. He holds board certification as a Fellow of the American Board of Forensic Toxicology (F- ABFT) and serves as Chair of the Oral Fluid Committee and former Chair of the SOFT/AAFS Drugs and Driving. In addition, he acts as a President for the International Association for Chemical Testing (IACT) and member of the National Safety Council’s Alcohol, Drugs and Impairment Division (NSC-ADID). Dr. Harper serves as an adjunct professor at the University of Alabama at Birmingham (UAB) in the Department of Justice Sciences, adjunct professor at Oklahoma State University within the School of Forensic Sciences, and faculty for the Borkenstein Alcohol Course at Indiana University. His interests include oral fluid drug testing, DUI/D testing and interpretation, and drug facilitated crimes. ADFS is the first state crime laboratory to implement a comprehensive DUI/D oral fluid drug testing program in the United States. As an Alabama Peace Officer, Dr. Harper has been certified as a Drug Recognition Expert since 2015 and acts as a member of the Alabama Impaired Driving Prevention Council. Prior to his appointment as Chief Toxicologist at ADFS, he served as Toxicology Supervisor in Richmond for the Virginia Department of Forensic Science for two years. Dr. Harper has testified on the effects of alcohol and other drugs in over 225 criminal or civil cases during his tenure in Alabama and Virginia.
Rob Hendrickson, MD
Professor of Emergency Medicine, Medical Director, Program Director
Oregon Health and Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology
Dr. Hendrickson graduated from the State University of New York, Downstate College of Medicine, and completed training in Emergency Medicine and Medical Toxicology at the Medical College of Pennsylvania. He is a Professor of Emergency Medicine at Oregon Health and Sciences University where he is Chief of the Section of Medical Toxicology, Program Director for the fellowship in medical toxicology, and the Medical Director of the Oregon Poison Center.
Glenn P. Jackson, PhD, FRSC, FAAFS
Professor of Forensic and Investigative Science
West Virginia University
Dr. Jackson is the Ming Hsieh Distinguished Professor of Forensic and Investigative Science at West Virginia University, where he also holds a joint appointment in the C. Eugene Bennett Department of Chemistry. Dr. Jackson earned a BS degree in the UK and MS and PhD degrees in the US, all in analytical chemistry. He is a fellow of the Royal society of Chemistry and of the American Academy of Forensic Sciences.
Dr. Jackson’s research is broadly defined as forensic and biological applications of mass spectrometry. Recent forensic applications include the mass spectral interpretation and identification of seized drugs, a model to understand the evaporation/weathering of ignitable liquids in fire debris, and the chemical analysis of human hair. His group's research has appeared in more than 90 publications, more than 160 conference and university presentations and three issued patents. As a PI or Co-PI at OHIO and WVU, he has helped secure more than $5M in state and federal funding.
Since 2016, Dr. Jackson has served as the Co-Founder and Co Editor-In-Chief of the Elsevier Journal, Forensic Chemistry. He recently served a three-year term on the NIST OSAC subcommittee on Seized Drugs, and he has taught numerous workshops to practicing forensic professionals. He is an active forensic chemistry consultant and has worked on more than three dozen legal cases. His work has appeared on Nancy Grace Live, Forensic Files II, Sundance TV, a WRAL “What Remains” podcast, and Law and Order SVU.
More information on the Jackson group can be found on his website (https://glenjackson.faculty.wvu.edu/).
Marc A. LeBeau, PhD F-ABFT
Senior Forensic Scientist in the Scientific Analysis Section
FBI Laboratory
Marc A. LeBeau, PhD, is a Senior Forensic Scientist of the Scientific Analysis Section at the FBI Laboratory. He has worked as a Forensic Chemist and Toxicologist for the FBI since 1994 and has testified in federal, state, and county courts throughout the United States. Separately, he is President of LeBeau Forensic Toxicology Consulting, LLC. Dr. LeBeau holds a bachelor’s degree in Chemistry and Criminal Justice from Central Missouri State University (1988) and a Master of Science degree in Forensic Science from the University of New Haven (1990). He was employed in the St. Louis County Medical Examiner’s Office (1990-1994), before beginning his career with the FBI. In 2005, he received his Doctorate in Toxicology from the University of Maryland–Baltimore.
As a Fellow of the American Board of Forensic Toxicology, Dr. LeBeau is active in numerous scientific organizations. He serves as the immediate Past-President of The International Association of Forensic Toxicologists (TIAFT) and is a Fellow of the American Academy of Forensic Sciences (AAFS). Additionally, Dr. LeBeau is a member and Past-President of the Society of Forensic Toxicologists (SOFT). Dr. LeBeau has spent much of his career advancing forensic sciences. He has served as a Commissioner on the National Commission on Forensic Science, the chairman of the Scientific Working Group on the Forensic Analysis of Chemical Terrorism (SWGFACT), and co-chair to the Scientific Working Group on the Forensic Analysis on Chemical, Biological, Radiological, and Nuclear Terrorism (SWGCBRN). He was also a co-chair of the Scientific Working Group for Forensic Toxicology (SWGTOX). He was the first Chair for the Forensic Toxicology Subcommittee of the Organization of Scientific Area Committees (OSAC). Currently he is the Chair of the OSAC’s Chemistry SAC for Seized Drugs and Toxicology. He also is the Chair of the AAFS Standards Board’s Toxicology Consensus Body.
In 2004 and 2020, Dr. LeBeau won the FBI Director’s Award for Outstanding Scientific Advancement, the 2008 End Violence Against Women (EVAW) International Visionary Award, and the 2015 Alexander O. Gettler Award, as well as the 2023 Rolla Harger Award from the Toxicology Section of the American Academy of Forensic Sciences in 2015.
Erin L. Karschner, PhD, F-ABFT
Forensic Toxicologist
Division of Forensic Toxicology, Armed Forces Medical Examiner System
Dr. Erin L. Karschner is a board-certified Forensic Toxicologist at the Armed Forces Medical Examiner System (AFMES) Division of Forensic Toxicology (DFT). The DFT supports the AFMES as the only federal medical examiner’s office in the U.S. and performs all investigative drug testing for the U.S. military and its installations worldwide. As part of her duties, she serves as a laboratory certifying official, expert witness, and subject matter expert. Dr. Karschner is an advisor on technical issues related to research initiatives, analytical challenges, and program development. She monitors emerging drug threats and assists in the implementation of effective analytical countermeasures.
Dr. Karschner received her Ph.D. in Toxicology with a concentration in Forensic and Analytical Toxicology from the University of Maryland-Baltimore. She performed her doctoral and post-doctoral research at the National Institute on Drug Abuse (NIDA). During her time at NIDA, Dr. Karschner conducted a clinical research study with cannabinoid pharmaceuticals and studied cannabinoid disposition in chronic cannabis smokers. After completing a post-doctoral fellowship at NIDA, she worked as a Research Scientist for a private laboratory where she developed and validated analytical methods for pain management medications, illicit drugs, and emerging designer drugs.
Dr. Karschner has 22 peer-reviewed publications and has presented her research at national and international venues. She is a member of the Society of Forensic Toxicologists (SOFT), the American Academy of Forensic Sciences (AAFS), and the International Association of Forensic Toxicologists (TIAFT). Her research was recognized by the SOFT Educational Research Award in 2009, the AAFS Toxicology Section June K. Jones Award in 2010, the AAFS Toxicology Section Irving Sunshine Award in 2018, and the TIAFT Best Bulletin Paper Award in 2021. Dr. Karschner currently serves on the SOFT/AAFS Drugs and Driving Committee and is the Cannabis Section Chair for the National Safety Council’s Alcohol, Drugs, and Impairment Division.
Charles McKay, MD, FACMT
Associate Medical Director
CT Poison Control Center, University of Connecticut School of Medicine
Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.
Jan Ramaekers, PhD
Professor of Psychopharmacology and Behavioral Toxicology
Maastricht University
I work as a professor in psychopharmacology at Maastricht University in the Netherlands. My research combines methods from psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug induced changes in human performance. In my work, I focus on the impact of different substances of (ab)use, including cannabis, stimulants, opioids, novel psychoactive substances (NPS) and psychedelics on neuronal networks and human cognition. This work bears relevance in the context of drug development and therapeutics and in legal settings when evaluating the impact of drug exposure on human function.
Friday, December 15: " Living in a Polydrug World - Lab and Medical Complexities"
Speaker InformationJoseph L. D’Orazio, MD, FAAEM, FACMT, FASAM, FCPP
Toxicology Consultant
Division of Toxicology and Addiction Medicine, Cooper Center for Healing
Dr. Joseph D'Orazio is board certified in Emergency Medicine, Medical Toxicology, and Addiction Medicine. He practices Medical Toxicology and Addiction Medicine for the Cooper Center for Healing at Cooper University Hospital in Camden, NJ. Dr. D’Orazio cares for patients who are admitted to Cooper University Hospital through the addiction medicine and toxicology inpatient consultative service and through the Cooper Center for Healing outpatient offices. Dr. D’Orazio is a medical toxicologist for the Poison Control Center at Children’s Hospital of Philadelphia and is regarded as a regional expert in substance use and substance use disorder treatment in the Philadelphia area.
Jennie V. Duval, MD
Chief Medical Examiner
Office of the Chief Medical Examiner
Jennie Duval was appointed Chief Medical Examiner for the State of New Hampshire on October 1, 2017 after serving as the Deputy Chief Medical Examiner for over 15 years. She earned her undergraduate degree from the University of New Hampshire and her medical degree from McGill University, Montreal, Quebec. She completed pathology residency training at the University of Massachusetts Medical Center and forensic pathology fellowship training at the Office of the Chief Medical Examiner in Boston. She teaches pathology and forensic pathology to medical students, physician assistant students and pathology residents at various institutions in New Hampshire. In addition, she has published several journal articles, presented numerous scientific papers at national professional society meetings and lectures frequently on various topics in forensic pathology including drug related deaths. During her career she has performed over 6,600 autopsies including over 1,700 drug related deaths.
James Gill, MD
Chief Medical Examiner
Office of the Chief Medical Examiner
James R. Gill MD is the Chief Medical Examiner of Connecticut, past Chair of the Forensic Pathology Committee of the College of American Pathologists (CAP), and a past President of the National Association of Medical Examiners (NAME). He has faculty medical appointments at Yale, University of Connecticut, and Quinnipiac University. He did his pathology training at Yale and Memorial Sloan-Kettering Cancer Center and his forensic pathology fellowship at the New York City Office of Chief Medical Examiner. Prior to Connecticut, he was the Deputy Chief Medical Examiner for Bronx County. He has testified over 450 times in criminal and civil matters in State and Federal courts and has published over 100 scientific articles and book chapters, and two books on a variety of forensic pathology topics. He has particular interests in public health including drug intoxication deaths, infectious disease, fatal complications of therapy, and proper death certification.
Andrew Holt, PharmD
Clinical Pharmacist & Fellowship Director
Aegis Sciences Corporation
Dr. Andrew Holt received his Doctor of Pharmacy degree from the University of Tennessee Health Science Center and is licensed to practice in multiple states. Prior to joining Aegis, Dr. Holt worked for the Tennessee Board of Pharmacy as Executive Director and was Director of Tennessee’s Prescription Drug Monitoring Program. He holds additional certifications in medical affairs, pharmacogenomics, and drugs in sport. Dr. Holt is an assistant professor for the Department of Clinical Pharmacy and Translational Science at the University of Tennessee College of Pharmacy, serves as a preceptor for six colleges of pharmacy and is a co-Director of the post-doctoral Fellowship Program, a collaboration with Belmont College of Pharmacy. One of his primary interests is the surveillance and detection of novel psychoactive substances and their role in overdoses.
Sherri Kacinko, PhD, F-ABFT
Forensic Toxicologist
NMS Labs
Dr. Sherri Kacinko is a senior toxicologist at NMS Labs in Horsham, PA. She earned her Ph.D. in toxicology from the University of Maryland – Baltimore. She is also adjunct faculty in the chemistry and forensic science departments at Arcadia University and serves as an Instructor at the Center for Forensic Science Research & Education. In her teaching roles, Dr. Kacinko lectures in pharmacology, postmortem toxicology, and human performance toxicology courses.
Dr. Kacinko is a fellow of the American Board of Forensic Toxicology (ABFT) and is a member of the Society of Forensic Toxicologists, the International Association of Forensic Toxicologists, and the American Academy of Forensic Sciences. She was presented with the American Academy of Forensic Sciences Toxicology Section Irving Sunshine Award in recognition of early career research and served as the program chair, secretary and chair of the AAFS toxicology section.
Current research interests include the identification and quantification of novel psychoactive substances and esoteric drugs including synthetic cannabinoids, stimulants, hallucinogens, opioids and benzodiazepines in biological fluids and their toxicological impact. Dr. Kacinko also uses data analytics to monitoring drug use trends on a local and national level.
Alex Krotulski, PhD
Associate Director of Toxicology & Chemistry
The Center for Forensic Science Research and Education
Dr. Alex Krotulski serves as an Associate Director at CFSRE working in the areas of forensic toxicology and forensic chemistry and is the Program Manager for NPS Discovery. Dr. Krotulski holds faculty appointment and serves as the Assistance Program Director for the Thomas Jefferson University Master of Science in Forensic Toxicology (MSFT) program and was recently appointed as an Associate Editor for the Journal of Analytical Toxicology. Dr. Krotulski received his Doctor of Philosophy degree in Analytical Chemistry from Temple University in 2019 following receipt of his Master of Science degree in Forensic Science from Arcadia University in 2015 and Bachelor of Science in Chemistry from Loyola University New Orleans in 2013.
Karen McDonald, MPPAL, PMP
Lead
Toronto’s Drug Checking Service
Karen has over fifteen years of public sector experience, where she has informed public policy and contributed to health systems change. She has spent the past five years leading the design and implementation of Toronto’s Drug Checking Service, and is now responsible for the program’s continuation and expansion across Ontario. Karen has received international recognition as a leader in drug checking service provision and unregulated drug market surveillance and education.
Charles McKay, MD, FACMT
Associate Medical Director
CT Poison Control Center, University of Connecticut School of Medicine
Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.
MJ Menendez, JD
Senior Fellow and General Counsel
Center for Forensic Science Research and Education
M.J. Menendez, J.D. is Senior Fellow and General Counsel for the Center for Forensic Science Research and Education in Willow Grove, Pennsylvania. M.J. served on detail as the Department of Justice’s Organized Crime Drug Enforcement Task Forces Heroin, Opioid and Fentanyl Special Projects Coordinator from 2015 to 2019. M.J. served 13 years as an Assistant U.S. Attorney in Colorado, 10 years as a state prosecutor in Jefferson County, Colorado, and 3 years as a state court judge in Jefferson County, Colorado. M.J. is passionate about achieving well-resourced excellence in medicolegal death investigations, and she proudly works with the National Association of Medical Examiners as Chair of Strategic Planning and Chair of the Forensic Pathology Shortage / Workforce Remediation Subcommittee.
Donna Papsun, MS, D-ABFT-FT
Forensic Toxicologist & Business Scientist
MS Labs
Donna Papsun is a forensic toxicologist and business scientist with NMS Labs in Horsham, PA. She has dual Bachelor of Science degrees in Chemistry and Forensic & Investigative Science and a Master of Science degree in Pharmacology. She is also certified as a Diplomate in Forensic Toxicology through the American Board of Forensic Toxicology and is a member of both the Society of Forensic Toxicologists (SOFT) and the American Academy of Forensic Sciences (AAFS).
Ms. Papsun has been with NMS Labs since 2008, first as a bench analyst before promotion to toxicologist in 2012. Ms. Papsun’s main area of interest is novel psychoactive substances or NPS. As one of the two leaders of NMS’s NPS strategy team, she continuously works to help maintain NMS’s leadership in identifying the newest trends in the changing landscape of the designer drug market and developing tests for their detection in forensic toxicology casework. Ms. Papsun also serves in a secondary role as a business scientist, working to align the technical and scientific expertise of NMS Labs with commercial efforts.
Paul M. Wax, MD, FACMT
Executive Director
American College of Medical Toxicology (ACMT)
Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.
Instructions
Once you have completed your registration:
- Click the View Button to view each course.
- Click on the Contents tab on the day of live event. This is where you will be able view the Zoom link for the course as well as our event survey and downloadable Certificate of Attendance.
- Watch live event. You can use the Zoom link in the Learning Center to leave and enter the webinar during event.
- Complete the Survey. If you are completing CE or would like your Certificate of Attendance, completion of this survey is required.
- Download the Certificate of Attendance. This is only a record that you have attended the course.
In order to receive and download your CE certificate, please go to your CE product to complete the required steps and claim your CE certificate.
Hardware/Software Requirements
Computer or Other Internet-Enabled Device; Internet Connection; Browser.
Materials
None.
Prerequisites
None.
Format
This event is a live Webinar.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.
If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.
-
Register
- Non-member - Tier I - $450
- Non-member - Tier II - $400
- Non-member - Tier III - $350
- Non-member - Tier IV - $300
- Member - Tier I - $350
- Member - Tier II - $300
- Member - Tier III - $250
- Member - Tier IV - $200
- More Information
-
Contains 3 Component(s) Includes a Live Web Event on 12/14/2023 at 9:45 AM (EST)
Live Virtual Event - Thursday December 14, 2023
In partnership with:
Overview
2023 ACMT Seminar in Forensic Toxicology Day 1 - Cannabis and the Expanding World of Cannabinoids: Expanding Knowledge & Shaping Practice!
The American College of Medical Toxicology (ACMT) and the Center for Forensic Science Research and Education (CFSRE) are proud to present an unparalleled opportunity to delve into the medical-legal aspects surrounding cannabis and alternative cannabinoids. This 1-day virtual event on December 14, 2023 will bring together leading experts, researchers, and professionals from the field to explore the latest advancements and critical insights.
Lecture Highlights:
During the lecture, speakers will:
- Describe the historical milestones and legislative changes that have shaped the current landscape of cannabis legalization and the expanding world of cannabinoids.
- Analyze the impact of cannabis legalization in California, including the challenges, benefits, and lessons learned from the implementation of cannabis regulations in the state.
- Evaluate the medical toxicology perspective on the rise in cannabis use and associated adverse events, understanding the potential health risks and factors contributing to this increase in incidents.
- Assess the analytical challenges and adoption of new technologies in laboratory testing of cannabinoids, and recognize the importance of accurate and reliable results in ensuring public safety.
- Differentiate between acute and chronic cannabis use, as well as various routes of administration, and comprehend the pharmacological mechanisms underlying driving impairment caused by cannabinoids.
Don't miss this unique opportunity to engage with renowned experts in the field, network with like-minded professionals, and stay ahead of the curve in the ever-evolving landscape of cannabis and alternative cannabinoids.
Register now so you don’t miss this invaluable opportunity to hear from experts and unlock a wealth of knowledge in this fast-growing area of medicine and law!
Recommended By:
Target Audience
The course will be tailored to the interests of physicians and professionals of numerous specialties, including medical toxicology, forensics and laboratory medicine, addiction medicine, and the legal community.
Learner Objectives
After attending the event, participants should be able to:
- Recognize the historical and legislative drivers of cannabis legalization and cannabinoids.
- Evaluate laboratory testing challenges and pharmacological mechanisms of cannabinoids.
Agenda | December 14, 2023
9:45 - 10:00 AM ET | Opening Remarks
10:00 - 10:30 AM ET
How Did We Get Here? Cannabis Legalization, the Farm Bill, Cannabinoid Analogues, & Chemistry
Glen P. Jackson, PhD, Professor of Forensic & Investigative Sciences, West Virginia University, Morgantown, WV10:30 - 11:00 AM ET
Challenges with Prosecuting Marijuana DUIs and other Legal Questions Post Legalization
Deena Ryerson, Sr. Assistant Attorney General, DUII Resource Prosecutor, Oregon Department of Justice, Salem, OR11:00 - 11:30 AM ET
Medical Toxicology Perspective on the Rise in Use and Adverse Events with Cannabinoid Products
Robert G. Hendrickson, MD, FACMT, FACEP, FAACT, Director, Emergency Medicine Toxicology Fellowship; Associate Medical Director, Oregon Poison Center; Professor of Emergency Medicine, School of Medicine, Oregon Health & Science University, Portland, OR11:30 - 12:00 PM ET
Analytical Perspectives and Challenges for Adoption of Cannabinoid Methodology
Ayako Chan-Hosokawa, MS, D-ABFT, Toxicology Team Manager & Forensic Toxicologist, NMS Labs, Horsham, PA
12:00 - 12:30 PM ET | Break - 30 min
12:30 - 1:00 PM ET
Acute vs Chronic Cannabinoid Use and Different Routes of Administration
Natalie Desrosiers, PhD, F-ABFT, Forensic Laboratory Team Leader, Services de toxicologie, Royal Canadian Mounted Police, Ottawa, Canada1:00 - 1:30 PM ET
Pharmacological Mechanism Underlying Driving Impairment
Jan Ramaekers, PhD, Professor of Psychopharmacology and Behavioral Toxicology, Maastricht University, Maastricht, The Netherlands1:30 - 2:00 PM ET
State-wide Oral Fluid Program and Courtroom Experiences
Curt E. Harper, Ph.D., F-ABFT, Chief Toxicologist, Alabama Department of Forensic Sciences, Hoover, AL2:00 - 2:30 PM ET
AFMES Experience with Semi-Synthetic Cannabinoids: Both Analytical & Interpretative
Erin L. Karschner, PhD, F-ABFT, Division of Forensic Toxicology, Armed Forces Medical Examiner System, Dover, DE
2:30 - 3:00 PM ET | Break - 30 min
3:00 - 3:30 PM ET
The Value of Different Pieces of Toxicology Data for Testimony
Bruce Goldberger, PhD, Chief, Division of Forensic Medicine, Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL3:30 - 4:00 PM ET
ASB Standards - From Scope of Testing to Testimony
Marc LeBeau, PhD, F-ABFT, Senior Forensic Scientist in the Scientific Analysis Section, FBI Laboratory, Quantico, VA4:00 - 5:00 PM ET
Roundtable & Case DiscussionsPanel
Erin L. Karschner, PhD, F-ABFT, Division of Forensic Toxicology, Armed Forces Medical Examiner System, Dover, DE
Ayako Chan-Hosokawa, MS, D-ABFT, Toxicology Team Manager & Forensic Toxicologist, NMS Labs, Horsham, PA
Robert G. Hendrickson, MD, FACMT, FACEP, FAACT, Director, Emergency Medicine Toxicology Fellowship; Associate Medical Director, Oregon Poison Center; Professor of Emergency Medicine, School of Medicine, Oregon Health & Science University, Portland, OR
Charles McKay, MD, FACMT, Associate Medical Director, CT Poison Control Center, University of Connecticut School of Medicine, Farmington, CT
Moderator
Donna Papsun, MS, D-ABFT-FT, Forensic Toxicologist & Business Scientist, NMS Labs, Horsham, PARegistration Rates
Registration includes:
- Access to the live virtual event on December 14, 2023
- Access to the on-demand recording for one year after event
- Access to the Speaker slides
- Downloadable Certificate of Attendance
Member Rates
Member Tier I: Full, Affiliate, International, Emeritus
$200
Member Tier II: Fellows
$175
Member Tier III: Residents, International - Developing Country
$150
Member IV: Medical Students
$125Non-Member Rates
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"
$250
Non-member Tier II: Fellows, SPIs, Nurses, etc.
$225
Non-member Tier III: Educators & Emergency Responders
$200
Non-member IV: Residents & Students
$175Interested in becoming an ACMT Member? Contact our Membership Manager, Lauren Turner, at membership@acmt.net. Learn more at: www.acmt.net/membership
Interested in Continuing Education?
Continuing Education credit for this activity is provided by Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.
Purchase Continuing Education here!
Package Rates
Sign up for the both days of the 2023 ACMT Seminar in Forensic Toxicology and save $50!
Refunds and Cancellations
- Cancellations made 16 days or more in advance of the event date will receive a full refund less a 8% processing fee.
- Cancellations made within 15 days of the event date will not receive a refund.
All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance (family emergency, for example) and must be submitted in writing to events@acmt.net. For these instances, the full registration fee, minus a 6% processing fee, will be refunded. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Questions?
For any questions, please email us at events@acmt.net.
Instructions
Once you have completed your registration:
- Click on the Contents tab on the day of live event. This is where you will be able view the Zoom link for the course as well as the event survey and downloadable Certificate of Attendance.
- Watch live event. You can use the Zoom link in the Learning Center to leave and enter the webinar during event.
- Complete the Survey. If you are completing CE or would like your Certificate of Attendance, completion of this survey is required.
- Download the Certificate of Attendance. This is only a record that you have attended the course.
In order to receive and download your CE certificate, please go to your CE product to complete the required steps and claim your CE certificate.
Hardware/Software Requirements
Computer or Other Internet-Enabled Device; Internet Connection; Browser.
Materials
None.
Prerequisites
None.
Format
This event is a live Webinar.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.
If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.
Ayako Chan-Hosokawa, MS, D-ABFT-FT
Toxicology Team Manager & Forensic Toxicologist
NMS Labs
Ayako (Aya) Chan-Hosokawa is a Forensic Toxicologist and Toxicology Team Manager with NMS Labs in Horsham, PA. She earned her Bachelor of Science in Chemistry from Stockton University and her Master of Science in Chemistry from the University of Minnesota. Ms. Chan-Hosokawa is also certified as a Diplomate through the American Board of Forensic Toxicology (ABFT) and is a member of the Society of Forensic Toxicologists (SOFT), the American Academy of Forensic Sciences (AAFS), the International Association of Forensic Toxicologists (TIAFT), International Council on Alcohol, Drugs and Traffic Safety (ICADT) and National Safety Council (NSC). She currently serves on the SOFT/AAFS Drugs and Driving Committee, the SOFT Finance Committee, and the AAFS Awards Committee.
Ms. Chan-Hosokawa has testified over 130 times in various jurisdictions (for both prosecution and defense) and routinely provides written expert opinion reports. She also serves as a faculty member for the Pennsylvania District Attorneys Institute (PDAI) for their annual training of prosecutors and investigators and was involved in the 2021 updates to the National Safety Council’s Alcohol, Drugs, & Impairment Division’s recommendations for drug testing in DUID cases. Her recent publications include Emergence of Delta-8 Tetrahydrocannabinol and 11-Year Study of Fentanyl in Driving under the Influence of Drugs Casework.
Natalie Desrosiers, PhD, F-ABFT
Forensic Laboratory Team Leader
Services de toxicologie, Royal Canadian Mounted Police
Bruce Goldberger, PhD
Chief, Division of Forensic Medicine
Department of Pathology, Immunology and Laboratory Medicine, University of Florida
Dr. Bruce Goldberger is a Professor in the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida in Gainesville. Dr. Goldberger is the Co-Investigator of the National Drug Early Warning System (NDEWS), a consultant for the Florida Department of Health and the Centers for Disease Control and Prevention, and a member of the White House Office of National Drug Control Policy Evolving and Emerging Threats Committee. Dr. Goldberger is the President of the American Board of Forensic Toxicology and the Editor-in-Chief of the Journal of Analytical Toxicology, the official journal of the Society of Forensic Toxicologists and The International Association of Forensic Toxicologists. Dr. Goldberger is prolific in research and publication in the areas of clinical, medical, and forensic toxicology, as well as in the medicolegal investigation of death including the certification of the cause and manner of death.
Curt E. Harper, Ph.D., F-ABFT
Chief Toxicologist
Alabama Department of Forensic Sciences
Dr. Curt E. Harper has over 15 years of experience as a Forensic Toxicologist. He was appointed Chief Toxicologist for the Alabama Department of Forensic Sciences (ADFS) in 2012. As Chief Toxicologist, he oversees technical operations, method development and validation, and the quality assurance/quality control program, manages productivity, serves as training coordinator, and develops and maintains standard operating procedures. Dr. Harper has a Ph.D. in Pharmacology and Toxicology and a Master’s of Science in Forensic Science from the University of Alabama at Birmingham. He holds board certification as a Fellow of the American Board of Forensic Toxicology (F- ABFT) and serves as Chair of the Oral Fluid Committee and former Chair of the SOFT/AAFS Drugs and Driving. In addition, he acts as a President for the International Association for Chemical Testing (IACT) and member of the National Safety Council’s Alcohol, Drugs and Impairment Division (NSC-ADID). Dr. Harper serves as an adjunct professor at the University of Alabama at Birmingham (UAB) in the Department of Justice Sciences, adjunct professor at Oklahoma State University within the School of Forensic Sciences, and faculty for the Borkenstein Alcohol Course at Indiana University. His interests include oral fluid drug testing, DUI/D testing and interpretation, and drug facilitated crimes. ADFS is the first state crime laboratory to implement a comprehensive DUI/D oral fluid drug testing program in the United States. As an Alabama Peace Officer, Dr. Harper has been certified as a Drug Recognition Expert since 2015 and acts as a member of the Alabama Impaired Driving Prevention Council. Prior to his appointment as Chief Toxicologist at ADFS, he served as Toxicology Supervisor in Richmond for the Virginia Department of Forensic Science for two years. Dr. Harper has testified on the effects of alcohol and other drugs in over 225 criminal or civil cases during his tenure in Alabama and Virginia.
Rob Hendrickson, MD
Professor of Emergency Medicine, Medical Director, Program Director
Oregon Health and Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology
Dr. Hendrickson graduated from the State University of New York, Downstate College of Medicine, and completed training in Emergency Medicine and Medical Toxicology at the Medical College of Pennsylvania. He is a Professor of Emergency Medicine at Oregon Health and Sciences University where he is Chief of the Section of Medical Toxicology, Program Director for the fellowship in medical toxicology, and the Medical Director of the Oregon Poison Center.
Glenn P. Jackson, PhD, FRSC, FAAFS
Professor of Forensic and Investigative Science
West Virginia University
Dr. Jackson is the Ming Hsieh Distinguished Professor of Forensic and Investigative Science at West Virginia University, where he also holds a joint appointment in the C. Eugene Bennett Department of Chemistry. Dr. Jackson earned a BS degree in the UK and MS and PhD degrees in the US, all in analytical chemistry. He is a fellow of the Royal society of Chemistry and of the American Academy of Forensic Sciences.
Dr. Jackson’s research is broadly defined as forensic and biological applications of mass spectrometry. Recent forensic applications include the mass spectral interpretation and identification of seized drugs, a model to understand the evaporation/weathering of ignitable liquids in fire debris, and the chemical analysis of human hair. His group's research has appeared in more than 90 publications, more than 160 conference and university presentations and three issued patents. As a PI or Co-PI at OHIO and WVU, he has helped secure more than $5M in state and federal funding.
Since 2016, Dr. Jackson has served as the Co-Founder and Co Editor-In-Chief of the Elsevier Journal, Forensic Chemistry. He recently served a three-year term on the NIST OSAC subcommittee on Seized Drugs, and he has taught numerous workshops to practicing forensic professionals. He is an active forensic chemistry consultant and has worked on more than three dozen legal cases. His work has appeared on Nancy Grace Live, Forensic Files II, Sundance TV, a WRAL “What Remains” podcast, and Law and Order SVU.
More information on the Jackson group can be found on his website (https://glenjackson.faculty.wvu.edu/).
Marc A. LeBeau, PhD F-ABFT
Senior Forensic Scientist in the Scientific Analysis Section
FBI Laboratory
Marc A. LeBeau, PhD, is a Senior Forensic Scientist of the Scientific Analysis Section at the FBI Laboratory. He has worked as a Forensic Chemist and Toxicologist for the FBI since 1994 and has testified in federal, state, and county courts throughout the United States. Separately, he is President of LeBeau Forensic Toxicology Consulting, LLC. Dr. LeBeau holds a bachelor’s degree in Chemistry and Criminal Justice from Central Missouri State University (1988) and a Master of Science degree in Forensic Science from the University of New Haven (1990). He was employed in the St. Louis County Medical Examiner’s Office (1990-1994), before beginning his career with the FBI. In 2005, he received his Doctorate in Toxicology from the University of Maryland–Baltimore.
As a Fellow of the American Board of Forensic Toxicology, Dr. LeBeau is active in numerous scientific organizations. He serves as the immediate Past-President of The International Association of Forensic Toxicologists (TIAFT) and is a Fellow of the American Academy of Forensic Sciences (AAFS). Additionally, Dr. LeBeau is a member and Past-President of the Society of Forensic Toxicologists (SOFT). Dr. LeBeau has spent much of his career advancing forensic sciences. He has served as a Commissioner on the National Commission on Forensic Science, the chairman of the Scientific Working Group on the Forensic Analysis of Chemical Terrorism (SWGFACT), and co-chair to the Scientific Working Group on the Forensic Analysis on Chemical, Biological, Radiological, and Nuclear Terrorism (SWGCBRN). He was also a co-chair of the Scientific Working Group for Forensic Toxicology (SWGTOX). He was the first Chair for the Forensic Toxicology Subcommittee of the Organization of Scientific Area Committees (OSAC). Currently he is the Chair of the OSAC’s Chemistry SAC for Seized Drugs and Toxicology. He also is the Chair of the AAFS Standards Board’s Toxicology Consensus Body.
In 2004 and 2020, Dr. LeBeau won the FBI Director’s Award for Outstanding Scientific Advancement, the 2008 End Violence Against Women (EVAW) International Visionary Award, and the 2015 Alexander O. Gettler Award, as well as the 2023 Rolla Harger Award from the Toxicology Section of the American Academy of Forensic Sciences in 2015.
Erin L. Karschner, PhD, F-ABFT
Forensic Toxicologist
Division of Forensic Toxicology, Armed Forces Medical Examiner System
Dr. Erin L. Karschner is a board-certified Forensic Toxicologist at the Armed Forces Medical Examiner System (AFMES) Division of Forensic Toxicology (DFT). The DFT supports the AFMES as the only federal medical examiner’s office in the U.S. and performs all investigative drug testing for the U.S. military and its installations worldwide. As part of her duties, she serves as a laboratory certifying official, expert witness, and subject matter expert. Dr. Karschner is an advisor on technical issues related to research initiatives, analytical challenges, and program development. She monitors emerging drug threats and assists in the implementation of effective analytical countermeasures.
Dr. Karschner received her Ph.D. in Toxicology with a concentration in Forensic and Analytical Toxicology from the University of Maryland-Baltimore. She performed her doctoral and post-doctoral research at the National Institute on Drug Abuse (NIDA). During her time at NIDA, Dr. Karschner conducted a clinical research study with cannabinoid pharmaceuticals and studied cannabinoid disposition in chronic cannabis smokers. After completing a post-doctoral fellowship at NIDA, she worked as a Research Scientist for a private laboratory where she developed and validated analytical methods for pain management medications, illicit drugs, and emerging designer drugs.
Dr. Karschner has 22 peer-reviewed publications and has presented her research at national and international venues. She is a member of the Society of Forensic Toxicologists (SOFT), the American Academy of Forensic Sciences (AAFS), and the International Association of Forensic Toxicologists (TIAFT). Her research was recognized by the SOFT Educational Research Award in 2009, the AAFS Toxicology Section June K. Jones Award in 2010, the AAFS Toxicology Section Irving Sunshine Award in 2018, and the TIAFT Best Bulletin Paper Award in 2021. Dr. Karschner currently serves on the SOFT/AAFS Drugs and Driving Committee and is the Cannabis Section Chair for the National Safety Council’s Alcohol, Drugs, and Impairment Division.
Charles McKay, MD, FACMT
Associate Medical Director
CT Poison Control Center, University of Connecticut School of Medicine
Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.
Jan Ramaekers, PhD
Professor of Psychopharmacology and Behavioral Toxicology
Maastricht University
I work as a professor in psychopharmacology at Maastricht University in the Netherlands. My research combines methods from psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug induced changes in human performance. In my work, I focus on the impact of different substances of (ab)use, including cannabis, stimulants, opioids, novel psychoactive substances (NPS) and psychedelics on neuronal networks and human cognition. This work bears relevance in the context of drug development and therapeutics and in legal settings when evaluating the impact of drug exposure on human function.
Deena Ryerson
Sr. Assistant Attorney General & Oregon Traffic Safety Resource Prosecutor
Oregon Department of Justice
Deena Ryerson is a graduate of the University of Oregon, School of Law in 1998. She was admitted to the bar in 1998 and began working in civil litigation for two years. From there she went to the Washington County District Attorney’s office where she worked as a prosecutor for six years. During that time, she prosecuted countless DUII’s, both alcohol and drug related and helped to begin a county newsletter addressing DUII issues. During Deena’s time with Washington County, she conducted several trainings for law enforcement, junior prosecutors, and law clerks. She was selected as Oregon’s DUII Multi-Disciplinary Training Task Force Prosecutor of the Year for 2004. In July 2006, she became Oregon’s Traffic Safety Resource Prosecutor with the Department of Justice.
As a Traffic Safety Resource Prosecutor, she assists prosecutors and law enforcement across the state with questions relating to DUII prosecution. She provides training for new and seasoned prosecutors, including updates to DUII case law and alerts prosecutors to issues that surface through the defense of DUII cases. She is a member of Oregon’s DUII Multidisciplinary Task Force, the DRE Technical Advisory Committee, the Oregon Ignition Interlock Committee, and a liaison to the Governor’s Advisory Committee on DUII. Ms. Ryerson also trains new recruits at Oregon’s Department of Public Safety and Standards Training department and law enforcement across the state about DUII case law. Ms. Ryerson reviews all DUII legislation and is instrumental in drafting and editing proposed DUII legislation. She is a resource to answer any impaired driving related questions for many disciplines. In addition to her work in Oregon, has trained law enforcement officers and prosecutors in other states and has given presentations at several national conferences including Lifesavers and the National DRE Conference. She was named a DRE Ambassador at the National DRE Conference in 2015.
-
Register
- Non-member - Tier I - $250
- Non-member - Tier II - $225
- Non-member - Tier III - $200
- Non-member - Tier IV - $175
- Member - Tier I - $200
- Member - Tier II - $175
- Member - Tier III - $150
- Member - Tier IV - $125
- More Information
-
Contains 4 Component(s) Includes a Live Web Event on 12/12/2023 at 12:00 PM (EST)
Pediatric Cases
Pediatric Cases
Presenter: William Banner. Medical Director, University of Oklahoma College of Pharmacy, Edmond, OK
Learning Objectives
- Coming soon!
About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.
This webinar is for ACMT members only.
Nicholas Nacca, MD (Moderator)
Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Associate Fellowship Director of Medical Toxicology Fellowship Program
University of Rochester Medical Center
Dr. Nacca was born Rochester NY. He completed his undergraduate work at University of Rochester with a Bachelor of Science in Neuroscience. He completed medical school, Emergency Medicine residency training, and Medical Toxicology fellowship at SUNY Upstate Medical University and the Upstate Poison Control Center. He currently works as an Emergency Physician and Medical Toxicologist at University of Rochester Medical Center where he serves as the Director of Medical Toxicology. The Medical Toxicology consult service at URMC provides 24/7 call coverage for Strong Memorial Hospital and affiliates, fielding both inpatient and outpatient consultations for management of both intentional and unintentional ingestions, overdoses, and environmental exposures. Dr. Nacca’s focus is on Medical Toxicology and Emergency Medicine education, with interest in novel psychoactive substances and adulterated drugs of abuse.
William Banner, MD, FACMT
Medical Director
University of Oklahoma College of Pharmacy
Dr. William J. Banner is a pediatrician in Oklahoma City, Oklahoma and is affiliated with Integris Baptist Medical Center. He received his medical degree from University of Tennessee Health Science Center College of Medicine and has been in practice for more than 20 years.-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information